{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":2888,"total_is_capped":false,"direct_labels_cover":3,"predictions_cover":2888,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"7e571f374015","filters":{"topic":"Acute Myeloid Leukemia Research"}},"results":[{"id":"W4283271244","doi":"10.1038/s41375-022-01613-1","title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms","year":2022,"lang":"en","type":"review","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3904,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; Hospital for Sick Children","funders":"Sahlgrenska Akademin; National Cancer Institute; Department of Laboratory Medicine and Pathology, University of Washington; School of Medicine, Indiana University; University of Texas MD Anderson Cancer Center; Universitätsklinikum Jena; Hospital for Sick Children; University of California, San Diego; National University Cancer Institute, Singapore; Medizinischen Hochschule Hannover; Université de Montréal; Centre National de la Recherche Scientifique; School of Medicine, Stanford University; Fudan University; Institut Gustave-Roussy; Sahlgrenska Universitetssjukhuset; Vrije Universiteit Amsterdam; University of Oxford; Wellcome Trust; University of Southampton; University of Alabama; Texas Children's Hospital; Amsterdam University Medical Centers; Moffitt Cancer Center; Institut National de la Santé et de la Recherche Médicale; University of Washington; Memorial Sloan-Kettering Cancer Center; Knight Cancer Institute, Oregon Health and Science University; Universität Ulm; University of Texas Southwestern Medical Center; Imperial College London; Children's Hospital Los Angeles; National Institute for Health and Care Research; Assistance publique-Hôpitaux de Paris; Massachusetts General Hospital; Université Paris-Saclay; University of Alabama at Birmingham; Nationwide Children's Hospital; Cincinnati Children's Hospital Medical Center; Centre International de Recherche sur le Cancer; Göteborgs Universitet; Radboud Universiteit; Radboud Universitair Medisch Centrum; Università degli Studi di Milano; University of Pennsylvania","keywords":"Histiocyte; Myeloid; Disease; Hematologic Neoplasms; Medicine; Computational biology; Computer science; Biology; Pathology; Immunology; Cancer; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04478243319244866,"gpt":0.3376422626290177,"spread":0.292859829436569,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001045786,0.0003584656,0.001453509,0.0003341848,0.0004787921,0.00003601375,0.0005455898,0.0001946007,0.0001700445],"category_scores_gemma":[0.001246551,0.0002208232,0.0002507881,0.00205353,0.0004759075,0.00007693309,0.0003159161,0.0009819603,0.0000135445],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.006722751,"about_ca_system_score_gemma":0.009647319,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002367015,"about_ca_topic_score_gemma":0.0001117981,"domain_scores_codex":[0.9962679,0.0006537988,0.001237121,0.0004673174,0.0009733722,0.0004005513],"domain_scores_gemma":[0.995967,0.001234087,0.001335884,0.00104266,0.0002650968,0.0001552931],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007921431,0.0001330539,0.0003989306,0.04888215,0.0003601416,0.00001944406,0.0005562495,0.000005497936,0.00008669014,0.01055409,0.04955652,0.889368],"study_design_scores_gemma":[0.0008764591,0.0001519261,0.001116762,0.007322699,0.00073908,0.000668202,0.0002152588,0.0002153572,0.0001332644,0.0000890302,0.9882489,0.0002230242],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004876476,0.9936566,0.0000887586,0.001603309,0.000643023,0.002446415,0.0001317186,0.00005753667,0.000884958],"genre_scores_gemma":[0.00221637,0.9935517,0.0001284967,0.0001489261,0.0002853589,0.0001534119,0.0005584247,0.0001137136,0.002843597],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9386924,"threshold_uncertainty_score":0.9970903,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4246697467","doi":"10.1038/ng765","title":"MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia","year":2001,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1719,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Bristol-Myers Squibb; American Society of Hematology","keywords":"Biology; Chromosomal translocation; Leukemia; Hox gene; Gene; Haematopoiesis; Genetics; Cancer research; Gene expression; Stem cell","retraction":null,"screen_n_in":null,"score":{"opus":0.02572875568372505,"gpt":0.3114401792564607,"spread":0.2857114235727356,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000247113,0.0003106658,0.000361439,0.0001737482,0.0002102262,0.00005143933,0.0003555125,0.0006803591,0.0004267467],"category_scores_gemma":[0.0003829827,0.0002558069,0.0001428667,0.0005816437,0.000166643,0.00005177574,0.000113234,0.001629194,0.0000821573],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006504821,"about_ca_system_score_gemma":0.00077636,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000319404,"about_ca_topic_score_gemma":0.00006163143,"domain_scores_codex":[0.9977261,0.00008963629,0.0003167849,0.0005698432,0.0007095724,0.0005881056],"domain_scores_gemma":[0.9982199,0.0001334267,0.0000958607,0.0008450478,0.0003425388,0.0003632425],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001866028,0.0008716916,0.3467166,0.0007507005,0.0003220261,0.003048434,0.002634652,0.0001356822,0.4256955,0.0003338995,0.1485356,0.06908914],"study_design_scores_gemma":[0.003402109,0.0004153455,0.2788797,0.0003697266,0.0002053937,0.0008550546,0.0002590344,0.002577516,0.4300979,0.0004741524,0.2817978,0.0006662286],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9644882,0.004382072,0.004891864,0.001992937,0.0003250203,0.001258805,0.00009007296,0.0002465901,0.02232445],"genre_scores_gemma":[0.9615682,0.0008881316,0.02959567,0.0004876192,0.001078701,0.00009170259,0.0003701863,0.0000862197,0.005833514],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1332622,"threshold_uncertainty_score":0.9999894,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2109336877","doi":"10.1038/nature04980","title":"Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9","year":2006,"lang":"en","type":"article","venue":"Nature","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1524,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pediatric Oncology Group","funders":"National Institutes of Health; Damon Runyon Cancer Research Foundation","keywords":"Progenitor cell; Stem cell; Cancer stem cell; Biology; Haematopoiesis; Cancer research; Population; Cancer cell; Endothelial stem cell; Stem cell theory of aging; Cell biology; Immunology; Cancer; Genetics; Stem cell factor; Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01232919001631794,"gpt":0.2804131572389025,"spread":0.2680839672225845,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0001419995,0.0001978139,0.0002710897,0.0001460426,0.00008638368,0.00003895213,0.0001948108,0.001307118,0.0001624233],"category_scores_gemma":[0.00001946573,0.0001690083,0.0000789496,0.0005328255,0.00003021624,0.0001388614,0.00002897501,0.002595777,0.0003348284],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004558147,"about_ca_system_score_gemma":0.0002021139,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003976131,"about_ca_topic_score_gemma":0.00005211178,"domain_scores_codex":[0.9984004,0.00007094153,0.0002858043,0.0002774419,0.0005956066,0.0003697735],"domain_scores_gemma":[0.9991235,0.00008233911,0.00005054737,0.0003155839,0.0002305278,0.0001974992],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006726623,0.0002246867,0.004049466,0.0001194862,0.00006225739,0.0001195791,0.0006567015,0.000006695768,0.2754743,0.00005841957,0.7115847,0.006971134],"study_design_scores_gemma":[0.005568189,0.0003023066,0.02109081,0.0001125112,0.0001088207,0.00002328604,0.000367007,0.0006572423,0.6141487,0.00006832577,0.3571946,0.0003581912],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9802769,0.001078093,0.0001736511,0.004025387,0.0001585599,0.001066247,0.0003334128,0.0002046968,0.01268303],"genre_scores_gemma":[0.9917597,0.00001318664,0.0005751898,0.002472317,0.0004015076,0.0000524687,0.001810471,0.00004451401,0.002870613],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3543901,"threshold_uncertainty_score":0.9999894,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2076031927","doi":"10.1038/nature13038","title":"Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia","year":2014,"lang":"en","type":"article","venue":"Nature","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1429,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research; Hospital for Sick Children","keywords":"Haematopoiesis; Stem cell; NPM1; Cancer research; Biology; Progenitor cell; Myeloid; Mutation; Immunology; Genetics; Gene; Karyotype","retraction":null,"screen_n_in":null,"score":{"opus":0.008380715083805107,"gpt":0.2922844584368306,"spread":0.2839037433530255,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006594871,0.0001496978,0.0003810995,0.0002783459,0.00002677758,0.00001455551,0.0002763576,0.001125721,0.00005066824],"category_scores_gemma":[0.0001081019,0.0001287473,0.00009094078,0.000513531,0.00008404241,0.00009676956,0.00007686107,0.002471574,0.0001019671],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003353112,"about_ca_system_score_gemma":0.0002101345,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001781417,"about_ca_topic_score_gemma":0.00001034339,"domain_scores_codex":[0.998296,0.00009898713,0.000442769,0.0003353787,0.000531129,0.0002957056],"domain_scores_gemma":[0.9987879,0.000127651,0.0001498484,0.0006374611,0.0001889326,0.0001081988],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005123442,0.0001495958,0.009437173,0.0007438525,0.0001006745,0.0000716112,0.0008036327,0.00004619111,0.9598864,0.001724761,0.019309,0.007214815],"study_design_scores_gemma":[0.002955956,0.0001996589,0.05188239,0.0003181481,0.0001328615,0.0001292776,0.000142819,0.005942079,0.9328967,0.0005035407,0.004675093,0.0002214669],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962219,0.0004224146,0.0002566393,0.001069317,0.0001957845,0.0005414652,0.00001489356,0.00004843605,0.001229176],"genre_scores_gemma":[0.9944966,0.00008836012,0.0002987675,0.0003981383,0.0000911096,0.00002462217,0.00002158457,0.00003131811,0.004549538],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04244522,"threshold_uncertainty_score":0.9998298,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2514448720","doi":"10.1038/ng.3646","title":"Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution","year":2016,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1292,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"U.S. National Library of Medicine; National Cancer Institute; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Human Genome Research Institute; Howard Hughes Medical Institute","keywords":"Biology; Chromatin; Haematopoiesis; Stem cell; Lineage (genetic); Genetics; Hematopoietic stem cell; Leukemia; Computational biology; Enhancer; Myeloid; Epigenomics; Cancer research; Gene; Transcription factor; DNA methylation; Gene expression","retraction":null,"screen_n_in":null,"score":{"opus":0.02055692789550373,"gpt":0.2904839785553225,"spread":0.2699270506598188,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003447335,0.0002226791,0.000318433,0.0001409284,0.0001559973,0.0000492297,0.0001381251,0.0005465113,0.000104914],"category_scores_gemma":[0.000148643,0.0001531521,0.00004788364,0.0001937008,0.0002943758,0.00008589552,0.0002074452,0.0005492148,0.00001997047],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006875804,"about_ca_system_score_gemma":0.0001649375,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005491281,"about_ca_topic_score_gemma":0.000008768708,"domain_scores_codex":[0.9983042,0.00006760286,0.0003049494,0.0005482925,0.0004080718,0.0003668433],"domain_scores_gemma":[0.9987582,0.0001345607,0.00009894399,0.000554644,0.000201846,0.0002518008],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001022649,0.00009942699,0.03190215,0.0003198148,0.00002856486,0.00003761943,0.000202619,2.175485e-7,0.950123,0.0001078319,0.007516081,0.009560409],"study_design_scores_gemma":[0.004573629,0.0005412092,0.4205306,0.0002903225,0.00008306604,0.0001708516,0.0001160325,0.0001982679,0.5593491,0.000647842,0.01310394,0.0003951986],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9866806,0.01037705,0.000339863,0.0007236947,0.0000988667,0.0004429134,0.00001994434,0.00007570442,0.001241405],"genre_scores_gemma":[0.9941405,0.0006249301,0.003368349,0.0001660462,0.0004355742,0.00001169735,0.00001358842,0.00003957817,0.001199736],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3907739,"threshold_uncertainty_score":0.624536,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1600365609","doi":"10.1182/blood-2015-01-621664","title":"International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with &gt;30% blasts","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1149,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; Princess Margaret Cancer Centre; CancerCare Manitoba","funders":"","keywords":"Azacitidine; Medicine; Internal medicine; Hypomethylating agent; Phases of clinical research; Complete remission; Oncology; Clinical trial; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.01641405087413181,"gpt":0.2939353942663254,"spread":0.2775213433921936,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001261652,0.0001694103,0.0003141691,0.0002525866,0.00002275736,0.00001314977,0.0001628341,0.00005600185,0.000526542],"category_scores_gemma":[0.0001413021,0.0001248056,0.00003011706,0.0002836834,0.00009718516,0.0001086488,0.00007820658,0.0002323035,0.00002165496],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002004985,"about_ca_system_score_gemma":0.000449096,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001375865,"about_ca_topic_score_gemma":0.0001461515,"domain_scores_codex":[0.998026,0.00006498583,0.0002826683,0.0003227404,0.001056536,0.0002471099],"domain_scores_gemma":[0.9984392,0.00007580867,0.0001242518,0.0002886075,0.0008639288,0.0002081963],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003349852,0.01613339,0.9712701,0.00006164056,0.0004570967,0.0006750912,0.004045264,0.00002779384,0.00009737512,0.00001641992,0.003370305,0.0004956588],"study_design_scores_gemma":[0.2885272,0.01370056,0.6884015,0.0004202791,0.0002460176,0.00003931208,0.005803185,0.0000792838,0.0008877475,0.000003208984,0.00165394,0.0002377778],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968882,0.00002880038,0.00001896336,0.000151959,0.00004461292,0.001174736,0.000162423,0.00002465885,0.001505708],"genre_scores_gemma":[0.9981484,0.000002962564,0.0006093503,0.00005822153,0.00009477699,0.0001237099,0.0006153397,0.00003300754,0.0003142784],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2851773,"threshold_uncertainty_score":0.5765266,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2107027906","doi":"10.1182/blood-2014-11-610543","title":"Acute myeloid leukemia ontogeny is defined by distinct somatic mutations","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":977,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pediatric Oncology Group","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; National Cancer Institute; National Institutes of Health; Lady Tata Memorial Trust; Edward P. Evans Foundation; Harvard Catalyst; Leukemia and Lymphoma Society","keywords":"Biology; Mutation; Myeloid leukemia; Genetics; Leukemia; Myeloid; Cancer research; Somatic cell; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01265719220558681,"gpt":0.2708781713231564,"spread":0.2582209791175696,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002706961,0.0002497398,0.000413635,0.0001325127,0.000186246,0.00004877303,0.0002550648,0.000158011,0.0006560779],"category_scores_gemma":[0.0004348141,0.0002153599,0.0001507327,0.0003023427,0.000134617,0.00009637085,0.0001043547,0.0003743097,0.001347697],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003163073,"about_ca_system_score_gemma":0.000485618,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001647401,"about_ca_topic_score_gemma":0.00002631567,"domain_scores_codex":[0.99802,0.00008161507,0.0003731145,0.00042052,0.000545004,0.0005597592],"domain_scores_gemma":[0.9984604,0.0002633915,0.0000968509,0.0006928649,0.0001216277,0.0003649349],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004063524,0.002969759,0.08036127,0.0008906834,0.003531505,0.0005252868,0.003136391,0.000005435182,0.5669839,0.002046911,0.3137995,0.02534296],"study_design_scores_gemma":[0.06193078,0.003343033,0.143723,0.000545284,0.00719654,0.002504342,0.0005515532,0.01176524,0.6079897,0.00514102,0.1530156,0.002293903],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9752339,0.0002078921,0.001522718,0.002597426,0.00007781798,0.0005146956,0.0001056039,0.0002221374,0.01951783],"genre_scores_gemma":[0.9850893,0.00003980317,0.004920917,0.001257828,0.000261286,0.0001029078,0.000332482,0.00007139908,0.007924087],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1607839,"threshold_uncertainty_score":0.9994299,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2560012305","doi":"10.1038/nature20598","title":"A 17-gene stemness score for rapid determination of risk in acute leukaemia","year":2016,"lang":"en","type":"article","venue":"Nature","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":920,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"European Hematology Association","keywords":"Oncology; Medicine; Internal medicine; Induction chemotherapy; Stem cell; Chemotherapy; Cohort; Framingham Risk Score; Adverse effect; Gene signature; Transplantation; Gene; Biology; Gene expression; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.0170112728378844,"gpt":0.3197615308929687,"spread":0.3027502580550843,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004419002,0.0001212533,0.0002936992,0.0002589771,0.00002812683,0.000004969703,0.0001616258,0.0009287493,0.00007127062],"category_scores_gemma":[0.0007447427,0.00007591181,0.0000941589,0.0002982008,0.00006484778,0.00009961905,0.00004839494,0.0009201323,0.000007762387],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003457883,"about_ca_system_score_gemma":0.0002683725,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001185893,"about_ca_topic_score_gemma":0.00003697095,"domain_scores_codex":[0.9988657,0.000049743,0.000233029,0.0002564554,0.0003303777,0.0002647171],"domain_scores_gemma":[0.9988368,0.0003449776,0.0001123788,0.000329631,0.0002965191,0.00007974858],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003680857,0.0001767054,0.04372557,0.000413999,0.0001403906,0.0001545806,0.0005912916,8.071059e-7,0.3941713,0.0003152062,0.01879829,0.537831],"study_design_scores_gemma":[0.02190924,0.0009240037,0.2271362,0.001105886,0.0002939601,0.0001566136,0.0001256777,0.0008487937,0.7316682,0.001374681,0.01406767,0.000389078],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941354,0.0007724621,0.001816671,0.001584345,0.000136537,0.0008747774,0.0002193543,0.00002972608,0.0004307319],"genre_scores_gemma":[0.9928362,0.0002832348,0.004506979,0.0002235096,0.000168874,0.00007140297,0.00004599138,0.00002872188,0.001835109],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5374419,"threshold_uncertainty_score":0.7163365,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2773514102","doi":"10.1038/nm.4439","title":"The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions","year":2017,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":875,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Biology; KRAS; Neuroblastoma RAS viral oncogene homolog; Myeloid leukemia; Cancer research; Genetics; DNA methylation; STK11; Gene; microRNA; Mutation; Gene expression","retraction":null,"screen_n_in":null,"score":{"opus":0.01839391499378195,"gpt":0.3467394608742709,"spread":0.3283455458804889,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004752752,0.0002065704,0.0003912659,0.0002273522,0.0006928797,0.00006634308,0.0003404811,0.0001837435,0.0001381056],"category_scores_gemma":[0.0009989085,0.0001235119,0.00008053577,0.0002122905,0.0004819566,0.0001460263,0.000135899,0.001410378,0.000007756752],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001988624,"about_ca_system_score_gemma":0.0002590527,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002159956,"about_ca_topic_score_gemma":0.00002452898,"domain_scores_codex":[0.998167,0.00007735356,0.0004683133,0.0002942882,0.000698748,0.0002943106],"domain_scores_gemma":[0.99786,0.0003934836,0.0003315431,0.0007470629,0.0004614652,0.0002064244],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.004419425,0.0001965086,0.06559403,0.0008663069,0.002682342,0.002953318,0.007144972,0.00005308187,0.2747005,0.06584461,0.4496046,0.1259403],"study_design_scores_gemma":[0.01272397,0.001439477,0.901311,0.0005653498,0.001444927,0.002074787,0.001132234,0.002923726,0.006386116,0.005405401,0.06397332,0.0006197162],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9679551,0.01061425,0.000173554,0.01613625,0.0009626236,0.0005964576,0.00004707908,0.00003116729,0.003483521],"genre_scores_gemma":[0.9927815,0.002647233,0.001039689,0.0003112175,0.001588132,0.00003111748,0.0001926076,0.00002545375,0.001383052],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.835717,"threshold_uncertainty_score":0.6127468,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2830196912","doi":"10.1038/s41586-018-0317-6","title":"Prediction of acute myeloid leukaemia risk in healthy individuals","year":2018,"lang":"en","type":"article","venue":"Nature","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":861,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; Instituto de Salud Carlos III; Hellenic Health Foundation; Medical Research Council; Leukemia and Lymphoma Society; Clalit Health Services; Agència de Gestió d'Ajuts Universitaris i de Recerca; Associazione Italiana per la Ricerca sul Cancro; Abisch-Frenkel-Stiftung; National Institute for Health and Care Research; Generalitat de Catalunya; Cancer Research UK; Wellcome Trust; European Regional Development Fund; World Health Organization","keywords":"Haematopoiesis; Myeloid; Bone marrow; Somatic cell; Incidence (geometry); Medicine; Allele; Internal medicine; Cohort; Progenitor cell; Oncology; Gene; Immunology; Stem cell; Biology; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.01739391057448661,"gpt":0.3234536506395245,"spread":0.3060597400650379,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0006991381,0.0001377603,0.0003268662,0.0003764822,0.00005953162,0.000007516251,0.0001806552,0.001464171,0.0001893962],"category_scores_gemma":[0.0003713508,0.0001138672,0.00007038092,0.0007594458,0.0001735891,0.0001024634,0.00008890295,0.003997681,0.00007500134],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004084428,"about_ca_system_score_gemma":0.000533645,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001309196,"about_ca_topic_score_gemma":0.0000394705,"domain_scores_codex":[0.998298,0.0001029339,0.0003301215,0.0003118264,0.000590921,0.0003661635],"domain_scores_gemma":[0.9989372,0.00008679061,0.0001323083,0.0004244299,0.0002650204,0.000154281],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002994912,0.0002766309,0.8242927,0.0002281603,0.0004273147,0.0000837703,0.001820029,0.000001806351,0.01633177,0.0004226744,0.1349614,0.01815885],"study_design_scores_gemma":[0.005596779,0.002073909,0.9350415,0.0001733952,0.0001488446,0.00009739301,0.0001295824,0.0004093805,0.02102208,0.0003981472,0.03478436,0.0001246665],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908321,0.0006922465,0.00002837735,0.002484637,0.0002739035,0.0005170367,0.0002771909,0.00006014671,0.004834332],"genre_scores_gemma":[0.9949281,0.0005879982,0.00171062,0.001419277,0.0006241247,0.0000175191,0.0001071117,0.00002697905,0.0005783369],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1107488,"threshold_uncertainty_score":0.9998322,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2079025304","doi":"10.1056/nejmoa0901409","title":"High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia","year":2009,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":822,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Saint-Luc; Institut du Savoir Montfort","funders":"Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung","keywords":"Medicine; Daunorubicin; Cytarabine; Gastroenterology; Regimen; Leukemia; Myeloid leukemia; Adverse effect; Internal medicine; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.009801749104587323,"gpt":0.2710433147508526,"spread":0.2612415656462653,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009726788,0.0002950174,0.0009693913,0.0007271072,0.00004531855,0.00001292851,0.000273551,0.000137232,0.000355003],"category_scores_gemma":[0.0003802553,0.0001687426,0.00007280537,0.0006645954,0.0001394327,0.0002228037,0.00002763829,0.001275821,0.00001425643],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000758847,"about_ca_system_score_gemma":0.001140837,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002603162,"about_ca_topic_score_gemma":0.0000457539,"domain_scores_codex":[0.9969603,0.0001161824,0.0008515581,0.000252057,0.001304586,0.0005152915],"domain_scores_gemma":[0.99795,0.0001867356,0.0003666595,0.0003458906,0.0004631245,0.0006875746],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.03072117,0.0008413905,0.1856543,0.00009858851,0.0006824077,0.01189286,0.003720792,0.0001909422,0.01184303,0.0003228982,0.08468413,0.6693475],"study_design_scores_gemma":[0.2395591,0.009780741,0.7372137,0.00122074,0.0003424803,0.001807495,0.0001251364,0.00004703318,0.0007458314,0.0003731839,0.008581124,0.0002034072],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9797564,0.0004763051,0.0003066085,0.01746714,0.0002732545,0.0004033707,0.00000272124,0.00001850219,0.001295762],"genre_scores_gemma":[0.9907488,0.0004975185,0.002181758,0.002630028,0.002717277,0.000001326478,0.00002965234,0.00003373558,0.001159895],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6691442,"threshold_uncertainty_score":0.6881121,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1998367819","doi":"10.1038/ng.2413","title":"Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis","year":2012,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":808,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Heart Institute; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Howard Hughes Medical Institute","keywords":"Biology; Somatic cell; Haematopoiesis; Myeloid; Exome sequencing; Somatic evolution in cancer; Genetics; DNA methylation; Mutation; Exome; Stem cell; Cancer research; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01481790548390875,"gpt":0.3101964165340708,"spread":0.2953785110501621,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003413399,0.000183403,0.000270446,0.0002829459,0.00006584159,0.00002287197,0.0001576101,0.0003476364,0.0001596169],"category_scores_gemma":[0.0001733915,0.0001422921,0.00005086234,0.0005682783,0.00009560836,0.0000899299,0.00007120743,0.001189093,0.00008020746],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002238171,"about_ca_system_score_gemma":0.0003707775,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005844582,"about_ca_topic_score_gemma":0.00002902271,"domain_scores_codex":[0.9981799,0.0000655828,0.0002760063,0.0002051383,0.0007017989,0.000571588],"domain_scores_gemma":[0.9990575,0.0001371462,0.00007146366,0.0003310823,0.0001411238,0.0002616941],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001552693,0.0006161222,0.9715069,0.0003588242,0.000188588,0.00007555979,0.003202573,0.00003983399,0.001548731,0.0002284991,0.0033585,0.01872063],"study_design_scores_gemma":[0.004283136,0.0008798022,0.944808,0.0003370295,0.0002467001,0.0006702522,0.001005038,0.000415895,0.02277387,0.0003222751,0.0238116,0.0004463925],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9910432,0.00490061,0.000101632,0.001251363,0.0001495236,0.0005374724,0.00002660986,0.00003786367,0.001951719],"genre_scores_gemma":[0.9747884,0.0001011317,0.02403262,0.0002762669,0.0003214445,0.00005373171,0.0001041569,0.00003583225,0.0002863799],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02669885,"threshold_uncertainty_score":0.5802505,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3013447738","doi":"10.1182/blood.2020004856","title":"Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":756,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal","funders":"Genentech","keywords":"Venetoclax; Medicine; Internal medicine; Neutropenia; Febrile neutropenia; Hazard ratio; Chemotherapy regimen; Cytarabine; Adverse effect; Chemotherapy; Surgery; Oncology; Leukemia; Confidence interval; Chronic lymphocytic leukemia","retraction":null,"screen_n_in":null,"score":{"opus":0.0321181257161765,"gpt":0.3360420507156437,"spread":0.3039239249994672,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009748676,0.0003598949,0.00233117,0.000157457,0.0001117612,0.0000544436,0.0002536941,0.0002303779,0.0001204794],"category_scores_gemma":[0.01292051,0.0002746775,0.0009749715,0.0002676229,0.0001399807,0.00007345288,0.00005559885,0.000318331,0.00003159709],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003301485,"about_ca_system_score_gemma":0.002148186,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004767361,"about_ca_topic_score_gemma":0.000003936445,"domain_scores_codex":[0.9974532,0.00016374,0.0007705097,0.0005849138,0.0003788449,0.0006488058],"domain_scores_gemma":[0.9947076,0.003473827,0.0002518606,0.0003664266,0.0007444406,0.0004558564],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9580711,0.0003708548,0.000001559768,0.0001860102,0.001649222,0.00006141707,0.001194285,0.00002594233,0.008039362,0.00008849124,0.02929752,0.001014229],"study_design_scores_gemma":[0.9307827,0.004234286,3.433275e-7,0.00005992651,0.001477416,0.00001442153,0.0002562904,0.03879286,0.01462016,0.0001770094,0.009336777,0.0002478371],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8676347,0.00104368,0.02632007,0.02287738,0.0004688317,0.08031385,0.0001876901,0.0003557953,0.0007979897],"genre_scores_gemma":[0.9064168,0.0004829216,0.01526254,0.02602119,0.007801172,0.03992403,0.0005897361,0.0003717248,0.00312983],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04038982,"threshold_uncertainty_score":0.9999706,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3093370683","doi":"10.1038/s41586-020-2819-2","title":"Inherited causes of clonal haematopoiesis in 97,691 whole genomes","year":2020,"lang":"en","type":"article","venue":"Nature","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":744,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Human Genome Research Institute; National Institutes of Health; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institute on Aging","keywords":"Biology; Germline; Somatic cell; Genetics; Haematopoiesis; Germline mutation; Genome-wide association study; Stem cell; Genome; Gene; Mutation; Single-nucleotide polymorphism; Genotype","retraction":null,"screen_n_in":null,"score":{"opus":0.02745570677313671,"gpt":0.3117134168020279,"spread":0.2842577100288912,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001187222,0.0001152999,0.0003505205,0.0001362196,0.00001881037,0.000007537456,0.0001575844,0.0007177141,0.000308987],"category_scores_gemma":[0.000446747,0.0000959961,0.0000702663,0.0006849458,0.00007858576,0.00005522729,0.00009831633,0.002188483,0.00008113174],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000112492,"about_ca_system_score_gemma":0.0002786556,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000456792,"about_ca_topic_score_gemma":0.00002746884,"domain_scores_codex":[0.9988788,0.00004215157,0.0002146667,0.0002246114,0.0004103463,0.0002293686],"domain_scores_gemma":[0.9993964,0.00008054145,0.00004627074,0.0001969668,0.0001323722,0.0001474052],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00240044,0.0004653996,0.3662723,0.002434798,0.0004640067,0.002913271,0.007650571,0.00004128122,0.3899975,0.001547212,0.2133379,0.01247535],"study_design_scores_gemma":[0.008818612,0.0007755356,0.3981519,0.0004617001,0.0001272545,0.0001806758,0.002097631,0.001574268,0.111315,0.000289072,0.47567,0.0005383086],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9636214,0.005815078,0.000005766322,0.02811576,0.00004670109,0.0002996656,0.00004471659,0.00004759099,0.002003283],"genre_scores_gemma":[0.9927629,0.0001332495,0.001008912,0.004968895,0.0001889489,0.000009367553,0.00005499661,0.00002509172,0.0008476385],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2786825,"threshold_uncertainty_score":0.950799,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2086149372","doi":"10.1073/pnas.2034201100","title":"Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?","year":2003,"lang":"en","type":"review","venue":"Proceedings of the National Academy of Sciences","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":678,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health; Leukemia and Lymphoma Society","keywords":"Stem cell; Haematopoiesis; Leukemia; Biology; Progenitor cell; Cancer research; Hematopoietic stem cell; Cancer stem cell; Cell biology; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.06959034464232351,"gpt":0.3387884473112493,"spread":0.2691981026689258,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002010654,0.0003738681,0.001564102,0.0005944638,0.0001807334,0.00003469159,0.0008837386,0.0004495032,0.00004444534],"category_scores_gemma":[0.0001309627,0.0002215899,0.0003084406,0.001455355,0.001183831,0.0003547249,0.00033018,0.0007399743,0.000005695832],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000457724,"about_ca_system_score_gemma":0.0009433978,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000684045,"about_ca_topic_score_gemma":5.413327e-8,"domain_scores_codex":[0.9959722,0.00004031732,0.001234062,0.0005691971,0.001824576,0.0003596835],"domain_scores_gemma":[0.996318,0.000378293,0.002476636,0.00003765446,0.0006660246,0.0001234063],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009582742,0.001444606,0.004140751,0.6014225,0.0008530486,0.00000307467,0.002721959,0.000006274386,0.02623151,0.009298665,0.0136268,0.3392925],"study_design_scores_gemma":[0.01355237,0.004021353,0.01395411,0.2555449,0.00921239,0.004572195,0.01878076,0.001681554,0.1300678,0.004140488,0.5393938,0.005078332],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1194742,0.8720665,0.00000122763,0.0003513641,0.00004011326,0.00189503,0.0002496618,0.00002083474,0.00590106],"genre_scores_gemma":[0.06921104,0.9257866,0.000509318,0.0001397183,0.0001274815,0.00009167308,0.000002957842,0.00003788056,0.004093282],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.525767,"threshold_uncertainty_score":0.9036175,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2025338891","doi":"10.1182/blood-2013-01-466706","title":"A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":633,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Vancouver General Hospital","funders":"National Cancer Institute","keywords":"Gemtuzumab ozogamicin; Cytarabine; Medicine; Daunorubicin; Gastroenterology; Internal medicine; Randomization; Myeloid leukemia; Induction chemotherapy; Surgery; Randomized controlled trial; Leukemia; Chemotherapy; CD33","retraction":null,"screen_n_in":null,"score":{"opus":0.01245108116759154,"gpt":0.2732417503177,"spread":0.2607906691501085,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001113012,0.000159291,0.0003073908,0.0003241672,0.0000490696,0.00002054579,0.00007154774,0.0000831551,0.0000542424],"category_scores_gemma":[0.00002918135,0.0001203471,0.00001911307,0.0003398777,0.00006046466,0.0003565091,0.00004787702,0.0002710852,0.000009067797],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002251689,"about_ca_system_score_gemma":0.0001680028,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009021282,"about_ca_topic_score_gemma":0.00002176711,"domain_scores_codex":[0.9987311,0.00007003326,0.0002918792,0.0003009565,0.0003590623,0.0002469884],"domain_scores_gemma":[0.9992665,0.00002535568,0.0001085471,0.0002867542,0.0002228949,0.00008995048],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003465773,0.01170349,0.6928639,0.00008982953,0.0007691385,0.00009821921,0.004685783,0.000004474945,0.2718909,0.000006122182,0.00003186882,0.01439047],"study_design_scores_gemma":[0.07896952,0.005983644,0.8798008,0.0000615039,0.0001194416,0.00004898609,0.001000659,0.00004340008,0.03383509,0.000006920272,0.000004132793,0.0001259328],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976166,0.00004361597,0.00000210067,0.00006587112,0.00002005109,0.002105792,0.000005678402,0.00002729438,0.0001129857],"genre_scores_gemma":[0.9994286,0.0000815773,0.0001468984,0.00003621013,0.00004024912,0.0001069968,0.00003491185,0.00002975165,0.00009476729],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2380558,"threshold_uncertainty_score":0.4907613,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1999580244","doi":"10.1038/ng.913","title":"Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia","year":2011,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":601,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; University of Washington","keywords":"GATA2; Biology; Myeloid leukemia; Transactivation; Missense mutation; Genetics; Myelodysplastic syndromes; Cancer research; Mutation; Zinc finger; Myeloid; Leukemia; Gene; Transcription factor; Bone marrow; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.01504878893100059,"gpt":0.2598435909749958,"spread":0.2447948020439952,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001964204,0.0002981611,0.0004168345,0.0001990619,0.0001786286,0.00003499682,0.0002020915,0.0006363423,0.0001359479],"category_scores_gemma":[0.0002617064,0.0002433285,0.00005577085,0.0005918902,0.0003028724,0.00009218424,0.0001263973,0.001410979,0.00005113171],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005112502,"about_ca_system_score_gemma":0.0008323005,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004531744,"about_ca_topic_score_gemma":0.00007319255,"domain_scores_codex":[0.9979925,0.00005867668,0.0002667321,0.0004880425,0.0005860873,0.000608013],"domain_scores_gemma":[0.9986188,0.0001308691,0.00009527812,0.0004372883,0.000356852,0.0003609373],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009593345,0.002528233,0.7357766,0.00159436,0.01620834,0.0354331,0.01695928,0.0003613484,0.1019957,0.001838178,0.04870317,0.0290083],"study_design_scores_gemma":[0.006350501,0.002428591,0.9723696,0.0002774011,0.001267277,0.003011234,0.0004175103,0.002487888,0.00808228,0.0004265299,0.002230071,0.0006510873],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935645,0.001113423,0.00021174,0.000161056,0.0001697607,0.0005815538,0.0001024155,0.0001315858,0.003963992],"genre_scores_gemma":[0.9862472,0.0003466239,0.009656917,0.0004564316,0.00009821817,0.0000367756,0.0002041721,0.00008234737,0.002871278],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.236593,"threshold_uncertainty_score":0.992265,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2730666287","doi":"10.1038/nature22993","title":"Tracing the origins of relapse in acute myeloid leukaemia to stem cells","year":2017,"lang":"en","type":"article","venue":"Nature","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":582,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Occupational Cancer Research Centre; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Stem cell; Haematopoiesis; Myeloid; Progenitor cell; Medicine; Cancer research; Chemotherapy; Immunology; Biology; Oncology; Internal medicine; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.01777219974143713,"gpt":0.3241447359647333,"spread":0.3063725362232961,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000578074,0.0001505573,0.0003310105,0.0001538228,0.0001611218,0.00004102259,0.0006682827,0.0008332398,0.00004031785],"category_scores_gemma":[0.000182872,0.00009515181,0.00009427896,0.0002338066,0.0001052944,0.0001182181,0.0001967108,0.00388118,0.0000855108],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006986705,"about_ca_system_score_gemma":0.0003709696,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002244056,"about_ca_topic_score_gemma":0.0001330174,"domain_scores_codex":[0.998553,0.00004902701,0.0002369476,0.0002877469,0.0005112272,0.000362021],"domain_scores_gemma":[0.9982913,0.0001238828,0.0001148094,0.001178306,0.0001436102,0.0001481092],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002907142,0.0002999335,0.03914764,0.0005765064,0.000526173,0.002164574,0.007255583,0.0001150492,0.7201686,0.006726131,0.1370206,0.0830921],"study_design_scores_gemma":[0.00504947,0.0004530668,0.1213847,0.0007464812,0.0001780566,0.0001685366,0.0008322524,0.0004822648,0.7080057,0.000147919,0.1621792,0.0003722795],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9818046,0.0003768439,0.00001645211,0.01129921,0.0003051117,0.0006120634,0.00002429761,0.00002373128,0.005537694],"genre_scores_gemma":[0.9919264,0.00009407461,0.0005811684,0.001238163,0.0002022169,0.00001729903,0.000003564297,0.00002897908,0.005908129],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08271983,"threshold_uncertainty_score":0.9984169,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2021663709","doi":"10.1182/blood-2012-03-362608","title":"Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel","year":2012,"lang":"en","type":"review","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":575,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; Children's Hospital of Eastern Ontario","funders":"University of Calgary","keywords":"Medicine; Childhood leukemia; Myeloid leukemia; Pediatrics; Disease; Intensive care medicine; Malignancy; Leukemia; Internal medicine; Lymphoblastic Leukemia","retraction":null,"screen_n_in":null,"score":{"opus":0.05332780296015282,"gpt":0.3576143848579419,"spread":0.3042865818977891,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002259635,0.0003149107,0.0009514756,0.0003602334,0.00003383726,0.00002960743,0.0002857889,0.0002403485,0.0001299823],"category_scores_gemma":[0.00001603146,0.0002702104,0.0001072332,0.0001977098,0.0000864726,0.0001954334,0.0004014855,0.0004469335,0.00001268736],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003854989,"about_ca_system_score_gemma":0.0001537887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004711048,"about_ca_topic_score_gemma":0.00001387087,"domain_scores_codex":[0.998242,0.0001243982,0.000555965,0.000493442,0.0003000635,0.0002841025],"domain_scores_gemma":[0.9990263,0.00006429724,0.0001978682,0.0004503813,0.00004487212,0.0002162874],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000196872,0.0005201991,0.03046785,0.002091626,0.002239846,0.00003622061,0.0001411953,9.906162e-9,0.000001863891,0.00002431304,0.00032338,0.9641338],"study_design_scores_gemma":[0.01041524,0.0002197178,0.301596,0.05317768,0.01039909,0.0004430879,0.0001394052,0.000009893609,0.00003987433,0.00002295962,0.6227169,0.0008202104],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02079257,0.9766136,0.000004980594,0.000174005,0.00009710507,0.001482572,0.0006304834,0.00002604988,0.0001786573],"genre_scores_gemma":[0.001178257,0.9938265,0.001919837,0.00008904361,0.0002709097,0.0003485556,0.002238464,0.00005597669,0.00007241885],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9633136,"threshold_uncertainty_score":0.999975,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2025391163","doi":"10.1111/j.1365-2141.2009.07697.x","title":"Mutations of polycomb‐associated gene <i>ASXL1</i> in myelodysplastic syndromes and chronic myelomonocytic leukaemia","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":556,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Myelodysplastic syndromes; Haematopoiesis; Myeloid; Chronic myelomonocytic leukemia; Biology; Epigenetics; Cancer research; Gene; Comparative genomic hybridization; Mutation; Genetics; Genome; Immunology; Stem cell; Bone marrow","retraction":null,"screen_n_in":null,"score":{"opus":0.01471615633459713,"gpt":0.2851794044656786,"spread":0.2704632481310815,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005130639,0.0001531365,0.001062925,0.0005131112,0.00005853517,0.00002183135,0.0001783156,0.0002150532,0.0000638581],"category_scores_gemma":[0.00106497,0.0001682644,0.0001211253,0.0004636656,0.0002841504,0.0001547062,0.00004335658,0.0007302713,0.000006099793],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005383177,"about_ca_system_score_gemma":0.001083974,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001211525,"about_ca_topic_score_gemma":0.0001450685,"domain_scores_codex":[0.997878,0.0001837316,0.000971114,0.0001944092,0.0003325298,0.0004401881],"domain_scores_gemma":[0.9985558,0.0003497981,0.0004418857,0.0001393671,0.0003007569,0.0002124417],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.002177146,0.003049728,0.0599403,0.001614198,0.002030832,0.6634527,0.001858513,0.0005689235,0.1279193,0.002551991,0.01523136,0.119605],"study_design_scores_gemma":[0.01107474,0.002475328,0.1962435,0.001937119,0.0003053241,0.7779471,0.000252522,0.0009918751,0.006300251,0.002043225,0.0001678226,0.0002611413],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890302,0.008661968,0.0001539702,0.001524663,0.00009667638,0.0002262372,0.00001256476,0.00001399686,0.000279748],"genre_scores_gemma":[0.996962,0.001788422,0.0008339847,0.0002159244,0.0000506362,0.000002999451,0.00001335404,0.00002083782,0.0001118048],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1363032,"threshold_uncertainty_score":0.6861625,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2120566462","doi":"10.1182/blood-2011-11-391748","title":"IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":500,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; Institut National Du Cancer; National Institutes of Health; Institut Universitaire de France; Terry Fox Foundation; Canadian Institutes of Health Research; Leukemia and Lymphoma Society","keywords":"IDH2; Isocitrate dehydrogenase; IDH1; Cancer research; Lymphoma; Biology; Mutation; Angioimmunoblastic T-cell lymphoma; Pathology; Medicine; T cell; Immunology; Gene; Genetics; Enzyme","retraction":null,"screen_n_in":null,"score":{"opus":0.01762623685960488,"gpt":0.2717594181123393,"spread":0.2541331812527344,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001949075,0.0001148386,0.000192222,0.0001995621,0.00004562664,0.00001203427,0.0001000739,0.00008811983,0.0001739915],"category_scores_gemma":[0.0001729589,0.0001034042,0.00006472496,0.0003405678,0.00005453692,0.0001004307,0.00005379369,0.0001583198,0.0006616689],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002262879,"about_ca_system_score_gemma":0.0001993347,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001208249,"about_ca_topic_score_gemma":0.00001568089,"domain_scores_codex":[0.9988726,0.0000468285,0.0002003183,0.0001520868,0.0002577206,0.0004704691],"domain_scores_gemma":[0.9993033,0.0001030001,0.00004686821,0.0003008963,0.00005810307,0.0001877755],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001631839,0.01199754,0.8562395,0.0003959712,0.0002453435,0.0008321548,0.003616546,0.00001633768,0.1167567,0.0005362527,0.003837121,0.005363376],"study_design_scores_gemma":[0.01827541,0.0002195375,0.9194067,0.0001914113,0.0002441374,0.000357483,0.001193032,0.0001266309,0.05513195,0.00008708473,0.004492193,0.0002744679],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9885913,0.001748792,0.00005798514,0.0003397217,0.00008092216,0.0002996395,0.000009629306,0.00005304722,0.008819034],"genre_scores_gemma":[0.9975364,0.00003707403,0.0009315762,0.0001957651,0.0001938765,0.00005745963,0.00003161576,0.00002899074,0.0009872534],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06316716,"threshold_uncertainty_score":0.8504636,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4224290890","doi":"10.1056/nejmoa2117344","title":"Ivosidenib and Azacitidine in <i>IDH1</i> -Mutated Acute Myeloid Leukemia","year":2022,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":483,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"Servier; Agios Pharmaceuticals","keywords":"Azacitidine; Medicine; Placebo; Myeloid leukemia; Internal medicine; Hazard ratio; Clinical endpoint; Population; Oncology; Randomized controlled trial; Surgery; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.01712971759250661,"gpt":0.2887805397604379,"spread":0.2716508221679313,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002273686,0.0002324577,0.0008699419,0.0008175488,0.0001170002,0.00001225506,0.0002507197,0.00007291503,0.0009704539],"category_scores_gemma":[0.0005327254,0.0001690482,0.00007808851,0.0007837273,0.0001956784,0.0001436359,0.0001701169,0.001811043,0.000004862701],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009243836,"about_ca_system_score_gemma":0.001285466,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004398336,"about_ca_topic_score_gemma":0.00004267491,"domain_scores_codex":[0.9970067,0.0002591292,0.0008766862,0.0002491019,0.001166683,0.0004417688],"domain_scores_gemma":[0.9982356,0.0003811769,0.0003179301,0.0002422335,0.0001981022,0.0006249615],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.02093328,0.0002940858,0.05172461,0.0002428592,0.001089821,0.04258906,0.008974263,0.0004755799,0.3556592,0.0004294961,0.2180544,0.2995334],"study_design_scores_gemma":[0.4215765,0.01686169,0.04073457,0.001085626,0.001149466,0.1242035,0.003753153,0.001774708,0.007994995,0.002610224,0.3776016,0.0006539106],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9624831,0.003590802,0.0001233911,0.03107581,0.0004071503,0.0002994876,0.000008324728,0.00002149113,0.001990461],"genre_scores_gemma":[0.9901996,0.002223413,0.0006553273,0.002601883,0.002215243,0.000007025968,0.00002511617,0.00004396272,0.002028474],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4006432,"threshold_uncertainty_score":0.9999428,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2948900598","doi":"10.1016/s1470-2045(19)30150-0","title":"Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":479,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital","funders":"Daiichi-Sankyo; Incyte; National Cancer Institute; National Cancer Research Institute; Celgene","keywords":"Medicine; Cytarabine; Internal medicine; Chemotherapy; Salvage therapy; Chemotherapy regimen; Febrile neutropenia; Etoposide; Surgery; Mitoxantrone; Fludarabine; Phases of clinical research; Transplantation; Refractory (planetary science); Oncology; Gastroenterology; Neutropenia; Cyclophosphamide","retraction":null,"screen_n_in":null,"score":{"opus":0.09386240084003972,"gpt":0.4315224040450322,"spread":0.3376600032049925,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.004834981,0.0005160489,0.00322813,0.0002583583,0.0001560493,0.00008163437,0.001432463,0.000593186,0.002486354],"category_scores_gemma":[0.002403027,0.0003097717,0.0002146037,0.0006310203,0.0003593787,0.0002042657,0.0003945669,0.001940195,0.00102693],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001865642,"about_ca_system_score_gemma":0.002694064,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000237129,"about_ca_topic_score_gemma":0.0002518478,"domain_scores_codex":[0.9940971,0.001822007,0.001224247,0.0008429292,0.00061852,0.001395206],"domain_scores_gemma":[0.9915956,0.005741438,0.0005953174,0.001549245,0.0001963505,0.000322069],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9343994,0.002596127,0.00009135695,0.00005597408,0.0009621986,0.0008062828,0.001076899,0.000006421541,0.02712792,0.0002044086,0.02157367,0.01109932],"study_design_scores_gemma":[0.8707371,0.01471438,0.00009417959,0.0000802201,0.0003546975,0.00008397985,0.0004286719,0.005053406,0.0007152452,0.00004238156,0.1073774,0.0003183662],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9533827,0.0004359538,0.00002044603,0.01440867,0.001678913,0.01445404,0.00003886881,0.0001392828,0.0154411],"genre_scores_gemma":[0.9594557,0.003880829,0.002068767,0.01143362,0.003269628,0.002373901,0.0001666627,0.0002398731,0.01711098],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08580371,"threshold_uncertainty_score":0.9999354,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2169923083","doi":"10.1200/jco.2014.55.3628","title":"Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":472,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital; Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health; Children’s Oncology Group","keywords":"Gemtuzumab ozogamicin; Medicine; Hazard ratio; Internal medicine; Chemotherapy; Induction chemotherapy; Randomized controlled trial; Calicheamicin; Myeloid leukemia; Oncology; Confidence interval; CD33","retraction":null,"screen_n_in":null,"score":{"opus":0.02256369829522603,"gpt":0.3769498515563637,"spread":0.3543861532611377,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03040837,0.0005033675,0.004731571,0.0002824103,0.0001944137,0.00004932956,0.001080164,0.001210347,0.00002111917],"category_scores_gemma":[0.03483787,0.0002938317,0.000724497,0.0003636939,0.001420135,0.0002496355,0.0004546468,0.006117148,0.000007232105],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001878413,"about_ca_system_score_gemma":0.00532069,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003975934,"about_ca_topic_score_gemma":0.0005699129,"domain_scores_codex":[0.9836039,0.008410789,0.005220698,0.0008478055,0.0009931435,0.0009236983],"domain_scores_gemma":[0.9791607,0.01406898,0.004541187,0.0009907273,0.0003681628,0.0008702461],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8850654,0.002145953,0.01519838,0.000006923554,0.001935075,0.00029084,0.0003343009,0.00001940579,0.0008496751,0.0000174719,0.006423396,0.08771323],"study_design_scores_gemma":[0.8606508,0.03038516,0.1028652,0.0003293573,0.002118804,0.001014956,0.0001103301,0.0008246987,0.00009368915,0.0002794678,0.001058321,0.0002692472],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9877671,0.0004362515,0.0008419689,0.007205451,0.0009147219,0.002413624,0.0001403425,0.0000267364,0.0002537748],"genre_scores_gemma":[0.986454,0.004420017,0.003324318,0.001589259,0.00388046,0.00002824695,0.0001062125,0.00007517614,0.0001223134],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08766678,"threshold_uncertainty_score":0.9999514,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2574119868","doi":"10.1200/jco.2016.71.6712","title":"Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":470,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Seagen (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Internal medicine; Autologous stem-cell transplantation; Oncology; Lymphoma; Transplantation; Hematopoietic stem cell transplantation; Cumulative incidence; Myeloid; Cohort","retraction":null,"screen_n_in":null,"score":{"opus":0.08473478358565387,"gpt":0.4415167162783707,"spread":0.3567819326927169,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003241892,0.0001666513,0.001603966,0.0001212764,0.0001450163,0.00001861842,0.0003193587,0.0005456947,0.00008025422],"category_scores_gemma":[0.002571128,0.0001039152,0.0006045505,0.00004492174,0.0003979224,0.0002088645,0.00003651777,0.0005764851,0.00001861229],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004081623,"about_ca_system_score_gemma":0.002996724,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001455046,"about_ca_topic_score_gemma":0.00009285449,"domain_scores_codex":[0.9970432,0.0002854668,0.001617815,0.0002095214,0.0004996458,0.0003443564],"domain_scores_gemma":[0.9923218,0.004020585,0.002217422,0.0003112137,0.0007506254,0.0003782925],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04558216,0.00273208,0.8468803,0.000204364,0.001635627,0.007691077,0.0003110692,0.000008672637,0.0001033871,0.00007788358,0.004880278,0.08989315],"study_design_scores_gemma":[0.02826858,0.007597965,0.9562903,0.0001342143,0.0008923801,0.000667292,0.0001085009,0.000118948,0.0001705108,0.0001036387,0.005533135,0.0001145225],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868283,0.00006188935,0.0006073297,0.009753506,0.0005500423,0.0003761423,0.00002682586,0.00001318087,0.001782733],"genre_scores_gemma":[0.9913665,0.0001678296,0.004252513,0.001599358,0.0003770292,0.00002224508,0.000007086102,0.00002797403,0.002179454],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1094101,"threshold_uncertainty_score":0.5316059,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2414703178","doi":"10.1182/blood-2015-07-655860","title":"Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":454,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Institute of Cancer Research; Cancer Research UK; National Cancer Institute; National Institutes of Health; Institut National Du Cancer; Fondation de France","keywords":"Bone marrow; Stromal cell; Mesenchymal stem cell; Cancer research; Myeloid leukemia; Leukemia; Mitochondrion; In vivo; In vitro; Myeloid; Biology; Chemistry; Cell biology; Immunology; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.008614955398169194,"gpt":0.2380024435188264,"spread":0.2293874881206572,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001422183,0.0004339689,0.0006641755,0.0002541721,0.0001265606,0.00004355934,0.000354857,0.0003133511,0.001001323],"category_scores_gemma":[0.00004334561,0.0003145724,0.0002599312,0.0003334013,0.0001267449,0.0001685517,0.00009920141,0.0005155967,0.0008984084],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005802042,"about_ca_system_score_gemma":0.0004807336,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002592253,"about_ca_topic_score_gemma":0.00002934936,"domain_scores_codex":[0.9968454,0.0001071859,0.0004553177,0.0009125276,0.0007451906,0.0009343298],"domain_scores_gemma":[0.998281,0.0001292609,0.00005195864,0.0008005336,0.0001572432,0.0005800267],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003214051,0.0003717375,0.0002002548,0.00004090442,0.0006023939,0.0004276983,0.0006363827,8.855208e-7,0.9914072,0.000004857859,0.001154829,0.001938818],"study_design_scores_gemma":[0.02571347,0.0008413763,0.004571859,0.0002253957,0.0002735857,0.00008793805,0.00006019306,0.000005194015,0.9664063,0.00005576485,0.001371963,0.0003869423],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916777,0.00007504858,0.002277275,0.002218987,0.000307959,0.002510898,0.0003275347,0.0002040806,0.000400492],"genre_scores_gemma":[0.9851755,0.0001299373,0.005522085,0.0004974134,0.002071695,0.0003698088,0.00001918947,0.0001838578,0.006030475],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02500087,"threshold_uncertainty_score":0.9999306,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2786854070","doi":"10.1016/j.stem.2018.01.011","title":"Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies","year":2018,"lang":"en","type":"review","venue":"Cell stem cell","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":450,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"National Cancer Institute; Damon Runyon Cancer Research Foundation","keywords":"Biology; Haematopoiesis; Somatic evolution in cancer; Immunology; Cancer research; Evolutionary biology; Genetics; Stem cell; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.03664998042485567,"gpt":0.3074273032066217,"spread":0.270777322781766,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005800578,0.0006975979,0.002277284,0.0004904158,0.0001721087,0.00007825139,0.0003869006,0.0006292547,0.0002802768],"category_scores_gemma":[0.00002811847,0.0005539983,0.0004751848,0.0006835545,0.0002210933,0.00006508551,0.0005087858,0.0006185266,0.003672936],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001048731,"about_ca_system_score_gemma":0.0011163,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002529002,"about_ca_topic_score_gemma":0.000002594883,"domain_scores_codex":[0.9964694,0.0001900723,0.0008313177,0.0009955526,0.0006943208,0.0008193864],"domain_scores_gemma":[0.9975441,0.0002760823,0.0002793115,0.0009872904,0.0002334506,0.000679743],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001603544,0.0005888224,0.00009063014,0.5614768,0.0004174627,0.0009334694,0.001283368,2.764251e-7,0.000700621,0.0005271524,0.2730264,0.1607946],"study_design_scores_gemma":[0.0004335562,0.0003092533,0.000008991158,0.01061551,0.000875493,0.0005565261,0.0001819147,0.000005061538,0.0006778677,0.00001802274,0.985803,0.0005147794],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008112238,0.9796396,0.0001269592,0.00007942441,0.0002455034,0.001643814,0.00005156827,0.0001115806,0.01729026],"genre_scores_gemma":[0.0002187517,0.9443041,0.0009072449,0.0001181884,0.0005216412,0.0002452037,0.00007534459,0.000168707,0.05344078],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7127766,"threshold_uncertainty_score":0.9996911,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2968120913","doi":"10.1126/science.aax3649","title":"A dominant-negative effect drives selection of <i>TP53</i> missense mutations in myeloid malignancies","year":2019,"lang":"en","type":"article","venue":"Science","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":434,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Foundation Medicine; National Institute of General Medical Sciences; Instrumentariumin Tiedesäätiö; National Institutes of Health; Orionin Tutkimussäätiö; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Human Genome Research Institute; Henry and Marilyn Taub Foundation; Edward P. Evans Foundation; Howard Hughes Medical Institute; Celgene; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Leukemia and Lymphoma Society; AstraZeneca; Jane ja Aatos Erkon Säätiö; National Science Foundation","keywords":"Missense mutation; Biology; Genetics; Gene; Mutagenesis; Mutation; Tumor suppressor gene; Suppressor; Cancer research; Carcinogenesis","retraction":null,"screen_n_in":null,"score":{"opus":0.00899976534460787,"gpt":0.2973290718442946,"spread":0.2883293064996867,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009969217,0.00009876482,0.0002408642,0.0004410981,0.00007827243,0.00001734239,0.0001708393,0.00004419966,0.00007500622],"category_scores_gemma":[0.001122474,0.00007730307,0.0000437106,0.002086072,0.0006938384,0.0002528517,0.0000644166,0.000194818,0.0001090768],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002959899,"about_ca_system_score_gemma":0.0008529489,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001500753,"about_ca_topic_score_gemma":0.00004023016,"domain_scores_codex":[0.9985164,0.00007147829,0.0001977198,0.0003281182,0.0005391876,0.0003470789],"domain_scores_gemma":[0.9990011,0.0003579102,0.00007295915,0.0002159558,0.000254669,0.00009740968],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001329367,0.00003668967,0.05253333,0.00007425826,0.000004518382,0.0000170396,0.001299354,0.00005220234,0.9444996,0.000112995,0.00004194967,0.001195143],"study_design_scores_gemma":[0.001295921,0.0005989682,0.1808732,0.0001723269,0.00001091932,0.00008586477,0.0005470996,0.003007699,0.8131315,0.0001065356,0.00009003191,0.00008000237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962333,0.0000403523,0.00005424677,0.000306477,0.00008216766,0.000669417,0.000002928478,0.00001808548,0.002592964],"genre_scores_gemma":[0.9969511,0.00001491693,0.001605851,0.00005975575,0.00001849711,0.0000227246,0.000001420812,0.000007976766,0.00131777],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1313681,"threshold_uncertainty_score":0.3152328,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1974674483","doi":"10.1182/blood-2006-04-015560","title":"A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":413,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Myeloid leukemia; Medicine; Internal medicine; Fms-Like Tyrosine Kinase 3; Tyrosine-kinase inhibitor; Chemotherapy; Adverse effect; Oncology; Pharmacology; Leukemia; Chemotherapy regimen; Cancer; Biology; Mutation","retraction":null,"screen_n_in":null,"score":{"opus":0.02650563510070308,"gpt":0.3123375602894287,"spread":0.2858319251887256,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001646588,0.0003854419,0.0007682107,0.0001225066,0.0001755184,0.00002592109,0.0001835937,0.0001997154,0.00005311107],"category_scores_gemma":[0.000396316,0.0002296006,0.0003812943,0.000232638,0.0002459296,0.00007011835,0.00004837281,0.0001779111,0.000007677048],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004957649,"about_ca_system_score_gemma":0.001234208,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002483476,"about_ca_topic_score_gemma":0.00009894035,"domain_scores_codex":[0.997756,0.00004250314,0.0006323559,0.0005161437,0.0005043942,0.0005485803],"domain_scores_gemma":[0.9972055,0.0004922966,0.0003569108,0.0006421154,0.001155913,0.0001472432],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.817956,0.03682878,0.003865392,0.0006816083,0.00681538,0.0001382823,0.002889372,0.00004092909,0.04857442,0.0002661219,0.05009153,0.03185216],"study_design_scores_gemma":[0.6278931,0.01660444,0.0009397722,0.0001689689,0.001233527,0.0000354346,0.000130371,0.0001759712,0.3447972,0.00009453986,0.007683102,0.0002435198],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854622,0.00004982691,0.0002250312,0.003116111,0.0001618255,0.01007053,0.0007184701,0.00005165278,0.0001443706],"genre_scores_gemma":[0.9914669,0.00004026292,0.002458704,0.0009980884,0.0007864646,0.001303474,0.0003859295,0.0001193841,0.002440788],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2962228,"threshold_uncertainty_score":0.936284,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2163344214","doi":"10.1038/leu.2009.33","title":"New insights to the MLL recombinome of acute leukemias","year":2009,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":411,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Minimal residual disease; Myeloid leukemia; Fusion gene; Chromosomal translocation; Leukemia; Gene; Acute leukemia; Cancer research; Breakpoint; Biology; Acute lymphocytic leukemia; Medicine; Lymphoblastic Leukemia; Genetics; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.01953739838454069,"gpt":0.2949568201005775,"spread":0.2754194217160368,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002805353,0.0002781371,0.0005438964,0.0002806769,0.0001111243,0.00003286413,0.000629066,0.0002126608,0.0003290717],"category_scores_gemma":[0.000159764,0.0001835138,0.0002069099,0.001012279,0.00006965495,0.0001260795,0.0001468304,0.0007194837,0.0008335914],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001931131,"about_ca_system_score_gemma":0.002409144,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004986025,"about_ca_topic_score_gemma":0.00002914013,"domain_scores_codex":[0.9977074,0.00007422215,0.0005017184,0.000454097,0.0006780562,0.0005844866],"domain_scores_gemma":[0.997845,0.0001234801,0.0001147629,0.001172552,0.0001897901,0.0005544094],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001699835,0.0001274991,0.0009449093,0.00007225621,0.0005606202,0.0007438324,0.004050405,0.0001576905,0.1002642,0.006432951,0.7096139,0.1753319],"study_design_scores_gemma":[0.01252339,0.004464382,0.2120093,0.0005042045,0.0007817749,0.0008788908,0.0004171057,0.00152316,0.1373197,0.006798354,0.6217394,0.001040282],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9283035,0.0004827107,0.001445587,0.02155297,0.0003212939,0.001219401,0.00001210304,0.0001731399,0.04648934],"genre_scores_gemma":[0.9556379,0.0001887133,0.005299262,0.008087084,0.0006670685,0.00001799309,0.00003311125,0.00004678193,0.03002211],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2110644,"threshold_uncertainty_score":0.9999444,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2160746673","doi":"10.1056/nejmoa1010222","title":"Cytarabine Dose for Acute Myeloid Leukemia","year":2011,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":407,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Saint-Luc; Institut du Savoir Montfort","funders":"Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung","keywords":"Cytarabine; Medicine; Myeloid leukemia; Leukemia; Myeloid; Body surface area; Chemotherapy; Oncology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04713119116700721,"gpt":0.3266072343466176,"spread":0.2794760431796104,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001687569,0.0002525165,0.0009102164,0.0004590017,0.0000701296,0.000007423967,0.000323292,0.0001460999,0.001012301],"category_scores_gemma":[0.0009688443,0.0001552215,0.0001959053,0.0003102134,0.0002154099,0.0001616,0.00004494724,0.0007768106,0.00002503923],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000437538,"about_ca_system_score_gemma":0.001403923,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001812704,"about_ca_topic_score_gemma":0.00001453402,"domain_scores_codex":[0.9976527,0.00007164633,0.0008481495,0.0002162409,0.0007351912,0.0004760685],"domain_scores_gemma":[0.997414,0.0003124861,0.0003900073,0.0003471747,0.0006625107,0.0008738481],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.03407652,0.0002520587,0.006122821,0.0002432188,0.002361838,0.004071039,0.007293633,0.000007626776,0.09492851,0.001187477,0.3326066,0.5168486],"study_design_scores_gemma":[0.3997823,0.02646766,0.02855538,0.001404386,0.003552045,0.02519372,0.00077546,0.0004902161,0.02239449,0.006116224,0.4847311,0.0005370204],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9314716,0.003509552,0.01553082,0.0271055,0.001980779,0.001248982,0.00001598834,0.00007782785,0.01905893],"genre_scores_gemma":[0.9352492,0.002746461,0.02936205,0.003285334,0.01760098,0.00001286084,0.00003331723,0.0001118707,0.01159795],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5163116,"threshold_uncertainty_score":0.9999009,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2803360616","doi":"10.1038/s41586-018-0125-z","title":"Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host","year":2018,"lang":"en","type":"article","venue":"Nature","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":405,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute; Hôpital Maisonneuve-Rosemont; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Cancer Institute; Crohn's and Colitis Foundation; University of Chicago","keywords":"Haematopoiesis; Biology; Myeloid; Stem cell; Immunology; Epigenetics; Somatic cell; Cancer research; Lymphopoiesis; Myelopoiesis; Cell biology; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.00955968055772751,"gpt":0.3053104804324196,"spread":0.2957507998746921,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.000413866,0.0001805064,0.0002737171,0.0003187118,0.0000889072,0.00003715805,0.0001889818,0.001319089,0.0003190723],"category_scores_gemma":[0.0004726412,0.000150097,0.00007081345,0.0006288086,0.0001538769,0.0001002131,0.00009857854,0.003069427,0.0003241429],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006628154,"about_ca_system_score_gemma":0.0005863025,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005368509,"about_ca_topic_score_gemma":0.0001288593,"domain_scores_codex":[0.9982966,0.0000761066,0.0002666181,0.0004266425,0.000482521,0.0004515482],"domain_scores_gemma":[0.9989856,0.00007006045,0.00006164399,0.0003661783,0.0003805745,0.0001358972],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0009888445,0.0001826866,0.01030849,0.00007717697,0.00003952539,0.0001305431,0.002048984,0.000006687673,0.9359656,0.0002337066,0.04818752,0.001830266],"study_design_scores_gemma":[0.008941389,0.001637267,0.1527954,0.0006688682,0.00009014083,0.0004957307,0.0004223127,0.003409627,0.7595286,0.0002673831,0.07110299,0.0006403013],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892487,0.0004705576,0.00008373339,0.004563,0.000266327,0.000872809,0.00001981691,0.00007209212,0.004402981],"genre_scores_gemma":[0.9918706,0.00003504108,0.0009902809,0.003696078,0.0009563423,0.00003251096,0.00006791945,0.00003280949,0.002318458],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.176437,"threshold_uncertainty_score":0.9999774,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2002784005","doi":"10.1038/nature09999","title":"A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia","year":2011,"lang":"en","type":"article","venue":"Nature","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":380,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Vlaamse regering; Fonds Wetenschappelijk Onderzoek; Agentschap voor Innovatie door Wetenschap en Technologie; York University; National Cancer Institute; National Institutes of Health; Edward Mallinckrodt, Jr. Foundation; Memorial Sloan-Kettering Cancer Center; Irma T. Hirschl Trust; Alex's Lemonade Stand Foundation for Childhood Cancer; Howard Hughes Medical Institute","keywords":"Notch signaling pathway; HES1; Biology; Haematopoiesis; Cyclin-dependent kinase 8; Cancer research; Notch proteins; Stem cell; Myeloid; Cell biology; Cellular differentiation; Progenitor cell; Transcriptome; Signal transduction; Genetics; Gene; Gene expression","retraction":null,"screen_n_in":null,"score":{"opus":0.03378567249484475,"gpt":0.2885894207259861,"spread":0.2548037482311413,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005232614,0.0001718249,0.0002331922,0.0001403142,0.00009732269,0.0000165306,0.0002653788,0.001058178,0.0002074103],"category_scores_gemma":[0.0005714222,0.0001070475,0.0001225489,0.0003701624,0.00007265397,0.0001011652,0.00008009504,0.003315807,0.00005155575],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002744326,"about_ca_system_score_gemma":0.0003402698,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001546775,"about_ca_topic_score_gemma":0.000140216,"domain_scores_codex":[0.9986304,0.00002611428,0.0002087913,0.0003316524,0.0003759774,0.0004270437],"domain_scores_gemma":[0.9989297,0.000264149,0.00005761354,0.000435601,0.0002100164,0.0001029479],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.007911507,0.0006013909,0.005706495,0.0003689758,0.000260059,0.0001103366,0.002772643,0.00001153668,0.8405821,0.006993025,0.1072012,0.02748066],"study_design_scores_gemma":[0.01575734,0.001190639,0.4344712,0.0002820021,0.0002124159,0.0003160979,0.001124762,0.004762451,0.2740455,0.001297225,0.2659491,0.0005912867],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9214619,0.005091077,0.01084136,0.02002371,0.002424288,0.007074669,0.0002443919,0.000372166,0.03246646],"genre_scores_gemma":[0.9907488,0.00002685256,0.002395622,0.002922188,0.0005300421,0.0002312886,0.0000418385,0.00004604593,0.003057378],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5665366,"threshold_uncertainty_score":0.9989836,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2728241634","doi":"10.1182/blood-2017-04-777029","title":"DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":379,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Heart Institute; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont","funders":"Canadian Institutes of Health Research; Concordia University","keywords":"Biology; Haematopoiesis; Epigenetics; Genetics; Gene; Mutation; Myeloid; Population; Phenotype; Immunology; Medicine; Stem cell","retraction":null,"screen_n_in":null,"score":{"opus":0.01230611936815558,"gpt":0.2669459064091549,"spread":0.2546397870409993,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009632439,0.0001554262,0.0002661325,0.00006673529,0.0004276405,0.0001343764,0.00008753748,0.00008934627,0.00002772582],"category_scores_gemma":[0.00009043491,0.0001222795,0.0000276655,0.00002364971,0.0004369077,0.00008156257,0.0001940924,0.0001808505,0.000004097964],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001663363,"about_ca_system_score_gemma":0.00005693391,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004642348,"about_ca_topic_score_gemma":0.00003196024,"domain_scores_codex":[0.9990817,0.00003204072,0.0001503245,0.0003053673,0.0001747375,0.000255849],"domain_scores_gemma":[0.999208,0.00008842145,0.00005942549,0.0003385709,0.00004910695,0.0002564785],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005892593,0.0009940456,0.7627547,0.001094595,0.0009839586,0.0008320744,0.001266384,3.380722e-7,0.1887495,0.002191534,0.0005593142,0.03998431],"study_design_scores_gemma":[0.005011826,0.0002754462,0.9704861,0.0001330748,0.0004706027,0.0008373801,0.00009960322,0.0002585714,0.02093703,0.001236288,0.00009510198,0.0001589687],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950541,0.001747599,0.00004235821,0.001395317,0.00002177564,0.000329433,0.00003684755,0.00002498322,0.001347573],"genre_scores_gemma":[0.9965952,0.0007436389,0.00209547,0.00004928016,0.0001092857,0.00003004365,0.000008011671,0.000019534,0.0003495244],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2077314,"threshold_uncertainty_score":0.4986412,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2890325820","doi":"10.1038/s41586-018-0436-0","title":"The genetic basis and cell of origin of mixed phenotype acute leukaemia","year":2018,"lang":"en","type":"article","venue":"Nature","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":374,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"National Institute of General Medical Sciences; National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; Canada's Michael Smith Genome Sciences Centre; American Lebanese Syrian Associated Charities; St. Jude Children's Research Hospital","keywords":"Myeloid; Haematopoiesis; Biology; Phenotype; Cancer research; Genetic heterogeneity; Somatic cell; Immunology; B cell; Stem cell; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01005525437862627,"gpt":0.2942993459725573,"spread":0.284244091593931,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001965467,0.00009034338,0.0001986289,0.00005953255,0.00005690486,0.000005828571,0.0001660623,0.000491831,0.00007447926],"category_scores_gemma":[0.0001330876,0.0000543678,0.00004492467,0.0002544122,0.0003220584,0.00001971143,0.0000807176,0.0009691695,0.00001500221],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005616107,"about_ca_system_score_gemma":0.0002633534,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003274101,"about_ca_topic_score_gemma":0.0000209947,"domain_scores_codex":[0.9991329,0.00003941297,0.0001600825,0.0001565255,0.0003197313,0.0001913433],"domain_scores_gemma":[0.9990315,0.0001444106,0.00007207623,0.0003702055,0.0003054297,0.00007640271],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002168647,0.0001376289,0.04400262,0.0005259277,0.0005316209,0.00006602926,0.0009463608,8.230126e-7,0.6867059,0.001329268,0.2057877,0.05779751],"study_design_scores_gemma":[0.003483336,0.001082627,0.2211667,0.0001048028,0.0003524806,0.0000582832,0.0001904789,0.000475384,0.6699545,0.0005018274,0.1024569,0.000172667],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904364,0.003160264,0.00001949247,0.001132662,0.0001363302,0.0002124784,0.00001647942,0.00001095692,0.004874873],"genre_scores_gemma":[0.9939663,0.0005220168,0.00261767,0.0002196143,0.0002041512,0.000003319193,0.000004895659,0.0000168213,0.002445178],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1771641,"threshold_uncertainty_score":0.4210613,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2149787089","doi":"10.1182/blood.v99.4.1364","title":"In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":364,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Japan Society for the Promotion of Science; Ligue Genevoise Contre le Cancer; National Institute of Diabetes and Digestive and Kidney Diseases; Fonds De La Recherche Scientifique - FNRS; Australian Government; National Institutes of Health; American Cancer Society","keywords":"RUNX1; Platelet disorder; Missense mutation; Nonsense mutation; Haploinsufficiency; Frameshift mutation; Point mutation; Biology; Genetics; Leukemia; Mutation; Cancer research; Molecular biology; Gene; Immunology; Phenotype; Transcription factor","retraction":null,"screen_n_in":null,"score":{"opus":0.02523519962083143,"gpt":0.3024561867370647,"spread":0.2772209871162333,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000155948,0.000148228,0.0004291812,0.0004713634,0.00004903204,0.000005808389,0.00009935247,0.0001126292,0.000007987252],"category_scores_gemma":[0.00008436073,0.0001237473,0.0000566925,0.0006988784,0.00007549945,0.00007887712,0.00004601415,0.0001124966,0.000001071177],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001408712,"about_ca_system_score_gemma":0.0001738055,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005132062,"about_ca_topic_score_gemma":0.0002864267,"domain_scores_codex":[0.9988067,0.00002691133,0.0004091381,0.0003039367,0.0001755673,0.0002777229],"domain_scores_gemma":[0.999195,0.0001527961,0.0001031621,0.0002714844,0.0001780309,0.00009954173],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006179964,0.0009186965,0.001022456,0.0001084887,0.0001551819,0.00001780338,0.0006356954,0.0001510127,0.9943041,0.0003750137,0.00001631773,0.001677235],"study_design_scores_gemma":[0.01300217,0.001202858,0.05985191,0.00009671273,0.0005739954,0.0001632503,0.0003517661,0.001851107,0.9223801,0.0003352305,0.00001940608,0.0001715231],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9725718,0.0001460062,0.02426716,0.0008019949,0.00001006542,0.001443738,0.0006955811,0.000009589569,0.00005402327],"genre_scores_gemma":[0.9770129,0.00008032023,0.02216956,0.0000771171,0.00002265719,0.0004403855,0.0001146661,0.00002667768,0.00005573402],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07192403,"threshold_uncertainty_score":0.504627,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2159289068","doi":"10.1182/blood.v97.1.56","title":"A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children's Cancer Group","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":361,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Grace (Canada)","funders":"","keywords":"Medicine; Chemotherapy; Cytarabine; Regimen; Internal medicine; Surgery; Bone marrow; Chemotherapy regimen; Transplantation; Randomization; Leukemia; Oncology; Myeloid leukemia; Randomized controlled trial","retraction":null,"screen_n_in":null,"score":{"opus":0.0107190085006928,"gpt":0.2846117187186004,"spread":0.2738927102179076,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004032702,0.0003727475,0.0008723361,0.0002416796,0.0001033014,0.00002414079,0.0002248408,0.000272746,0.0001213327],"category_scores_gemma":[0.00004094634,0.0002630534,0.0000817645,0.0006805441,0.0002873046,0.0001302348,0.00002263138,0.0006727329,0.000002117006],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002647143,"about_ca_system_score_gemma":0.0007426005,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005838291,"about_ca_topic_score_gemma":0.00305201,"domain_scores_codex":[0.9971331,0.0001753566,0.0008646924,0.0007018869,0.0006200143,0.0005049623],"domain_scores_gemma":[0.9985493,0.0001528944,0.0004943213,0.0005105429,0.0001136374,0.0001792567],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003087815,0.0003875123,0.9562266,0.00006101465,0.000621558,0.004448202,0.002960086,0.00004538067,0.02865126,0.000005198302,0.0002480059,0.00325735],"study_design_scores_gemma":[0.01892306,0.0003198193,0.94368,0.0007359755,0.0006714135,0.01881375,0.0001323309,0.000135246,0.01622922,0.00003368074,0.0000414962,0.0002840419],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909521,0.005084733,0.0001127673,0.002065402,0.00002468176,0.001444966,0.0001635867,0.00005139457,0.0001003387],"genre_scores_gemma":[0.9818156,0.01476484,0.001721677,0.0003235175,0.0001291211,0.000175631,0.0008924808,0.0000628282,0.000114339],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01583525,"threshold_uncertainty_score":0.9999822,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2783692764","doi":"10.1038/nature25193","title":"A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies","year":2018,"lang":"en","type":"article","venue":"Nature","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":358,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Deutsches Krebsforschungszentrum","keywords":"Haematopoiesis; Enhancer; Biology; Stem cell; Progenitor cell; Myeloid; Transcription factor; RUNX1; Cell biology; Cancer research; Enhancer RNAs; Molecular biology; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.007558521614313518,"gpt":0.2731394814598352,"spread":0.2655809598455217,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0002319063,0.0001965924,0.0002980313,0.0001756514,0.0001343149,0.00004175971,0.0001593908,0.0009711433,0.00026274],"category_scores_gemma":[0.00004075508,0.0001478814,0.00006367494,0.0002636076,0.000374625,0.0001263533,0.000194047,0.002358279,0.0001932744],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001425918,"about_ca_system_score_gemma":0.000194909,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001315951,"about_ca_topic_score_gemma":0.00001672212,"domain_scores_codex":[0.9985328,0.00005751362,0.0001892501,0.0003727892,0.0004047616,0.0004428274],"domain_scores_gemma":[0.9990261,0.0001103333,0.00005062797,0.0004177652,0.0001969563,0.0001982805],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.004144882,0.0002943623,0.01629271,0.00272141,0.0003738164,0.0005692132,0.01246533,0.000002722424,0.3695989,0.001210209,0.5500949,0.0422315],"study_design_scores_gemma":[0.007976281,0.001437673,0.02765792,0.0006548585,0.000224519,0.001606827,0.0009910279,0.002062136,0.8143442,0.0008581222,0.1414445,0.0007419619],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9792128,0.00410481,0.00003139091,0.003948667,0.0001875626,0.0004035496,0.000008378597,0.00008542812,0.01201746],"genre_scores_gemma":[0.9717116,0.00018554,0.001179657,0.002377413,0.0006959603,0.00001762715,0.00001349899,0.00004075625,0.02377797],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4447452,"threshold_uncertainty_score":0.9999433,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2129077074","doi":"10.1016/j.ccell.2015.05.004","title":"Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia","year":2015,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":349,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research; University of British Columbia; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto; Occupational Cancer Research Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Gene knockdown; Myeloid leukemia; K562 cells; Biology; Mitochondrion; Oxidative phosphorylation; Molecular biology; Mitochondrial respiratory chain; Cell culture; Small hairpin RNA; Cell biology; Haematopoiesis; Leukemia; Biochemistry; Cancer research; Stem cell; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.05606377012581656,"gpt":0.3487140045853986,"spread":0.2926502344595821,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001903064,0.000176242,0.0002856224,0.00004864356,0.00009538847,0.00002100039,0.0001923501,0.0001552137,0.0001916727],"category_scores_gemma":[0.00004048515,0.0001199301,0.0001644683,0.0001983097,0.0001759879,0.00009307541,0.00006965549,0.0003051553,0.00003423617],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001528477,"about_ca_system_score_gemma":0.00327732,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001074156,"about_ca_topic_score_gemma":0.00009943519,"domain_scores_codex":[0.9985476,0.00007455404,0.0002880299,0.000297799,0.0004415689,0.000350463],"domain_scores_gemma":[0.9987434,0.00003550849,0.0001520893,0.0004734288,0.0003768635,0.0002187286],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002040264,0.0001340701,0.0002832836,0.0003329399,0.000191334,0.00001857786,0.00121883,0.00007828628,0.9685404,0.0004653456,0.02190868,0.004787953],"study_design_scores_gemma":[0.01343229,0.001617272,0.000379178,0.0001936814,0.0005026386,0.00002056567,0.0008615405,0.0004191279,0.946661,0.004306804,0.03134375,0.0002621483],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9840757,0.001599392,0.0003536802,0.000986746,0.000491903,0.003946965,0.00009910669,0.00005239088,0.008394098],"genre_scores_gemma":[0.987587,0.00008813627,0.0002964017,0.0006880012,0.001066349,0.0007902336,0.0000590833,0.00005507666,0.009369724],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02187944,"threshold_uncertainty_score":0.5813825,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3036033661","doi":"10.1186/s40164-020-00170-6","title":"Leukemia incidence trends at the global, regional, and national level between 1990 and 2017","year":2020,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":348,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Medical Association","funders":"Department of Education of Guizhou Province; Guizhou Science and Technology Department; National Natural Science Foundation of China","keywords":"Medicine; Leukemia; Incidence (geometry); Myeloid leukemia; Chronic lymphocytic leukemia; Internal medicine; Demography","retraction":null,"screen_n_in":null,"score":{"opus":0.1203646384638414,"gpt":0.4121852002020398,"spread":0.2918205617381984,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001899996,0.0001606576,0.0004064975,0.00004526052,0.0002950294,0.00001096411,0.0001024192,0.000252199,0.0001505177],"category_scores_gemma":[0.00008863221,0.00011745,0.00003205544,0.0001244393,0.001269916,0.00007447231,0.0004391785,0.0002808933,0.00002909127],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006533529,"about_ca_system_score_gemma":0.0003448327,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008978256,"about_ca_topic_score_gemma":0.00005072707,"domain_scores_codex":[0.9987877,0.0001201109,0.0002205359,0.0004035677,0.0002022824,0.0002658294],"domain_scores_gemma":[0.9991583,0.000347142,0.00007524143,0.0001103837,0.00003773433,0.0002712389],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003176021,0.000201152,0.4926668,0.0001714173,0.0005128492,0.001517519,0.006000319,8.385849e-7,0.01216174,0.05806495,0.4138475,0.01167885],"study_design_scores_gemma":[0.01675089,0.005506565,0.5875785,0.00009299455,0.000221263,0.04622916,0.005578185,0.0009492885,0.02880698,0.002240438,0.3052614,0.0007843305],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9437476,0.01133154,0.00001646514,0.03920551,0.00004139046,0.0001872648,0.00003318991,0.00002746913,0.005409581],"genre_scores_gemma":[0.9923555,0.0003517853,0.0005397078,0.006064028,0.0001554583,0.00003746539,0.00004728978,0.000009425511,0.0004393004],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1085861,"threshold_uncertainty_score":0.478947,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2023728706","doi":"10.1126/science.1139851","title":"Modeling the Initiation and Progression of Human Acute Leukemia in Mice","year":2007,"lang":"en","type":"article","venue":"Science","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":344,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec; Hôpital de l'Enfant-Jésus; University of Toronto; University Health Network","funders":"","keywords":"Biology; Haematopoiesis; Leukemia; Myeloid; Myeloid leukemia; Cancer research; Lineage (genetic); Transplantation; Immunoglobulin heavy chain; Fusion gene; Immunology; Germline; Gene; Stem cell; Antibody; Genetics; Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.0366922530889922,"gpt":0.387397570942529,"spread":0.3507053178535368,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002100671,0.00004200062,0.00007505427,0.0001805374,0.0001199062,0.00001319564,0.0001471649,0.00002891921,0.000003506846],"category_scores_gemma":[0.0001551592,0.00002603678,0.000009374361,0.0006606761,0.0004191874,0.0001562108,0.00009627805,0.0001708094,0.000001717843],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000336827,"about_ca_system_score_gemma":0.0004486141,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008385202,"about_ca_topic_score_gemma":0.00003583701,"domain_scores_codex":[0.9990544,0.0000132133,0.0001500483,0.0001569631,0.0004152368,0.0002101791],"domain_scores_gemma":[0.9996256,0.00003773991,0.00003110075,0.0001354813,0.0001114083,0.00005865841],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00006016876,0.00001370922,0.008193965,0.00002277506,0.000002288825,0.00001966778,0.001760815,0.00009858316,0.9775999,0.0004445976,0.00001088379,0.01177271],"study_design_scores_gemma":[0.002061934,0.0004932159,0.1635957,0.0004269298,0.00002632438,0.0001135582,0.002162575,0.381878,0.4479748,0.001071839,0.00004483549,0.0001502044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971592,0.0000944483,0.0006405768,0.0002668925,0.00001883513,0.0002054306,3.492694e-7,0.000008238787,0.001605995],"genre_scores_gemma":[0.998781,0.00002259436,0.001033972,0.00008930079,0.00002349471,0.000002865781,9.432395e-7,0.000003300875,0.00004251489],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.529625,"threshold_uncertainty_score":0.1544513,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2530614832","doi":"10.1038/leu.2016.275","title":"Isocitrate dehydrogenase mutations in myeloid malignancies","year":2016,"lang":"en","type":"review","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":343,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; Celgene","keywords":"IDH2; Isocitrate dehydrogenase; Biology; Myeloid leukemia; IDH1; Myeloid; Cancer research; Myelodysplastic syndromes; Epigenetics; Histone; Mutation; Genetics; Gene; Biochemistry; Enzyme; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.04582845719732767,"gpt":0.3516455735021188,"spread":0.3058171163047911,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005611064,0.0006871701,0.002390474,0.0008633948,0.0001011227,0.00005083349,0.0004818346,0.0008335818,0.0006249361],"category_scores_gemma":[0.0004548281,0.0004787372,0.0007410391,0.001135439,0.0002819952,0.000142237,0.0001939504,0.001336829,0.003916742],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.0073331,"about_ca_system_score_gemma":0.00874381,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000123688,"about_ca_topic_score_gemma":0.00004210253,"domain_scores_codex":[0.9962277,0.0002723512,0.00108827,0.0008354521,0.0005775248,0.0009987231],"domain_scores_gemma":[0.9976674,0.0005137438,0.0003083895,0.0009770433,0.0001441356,0.000389301],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003041109,0.00005277294,0.00003258518,0.01581615,0.0003016045,0.001982425,0.0001397163,0.000001544255,0.00006523934,0.0005729954,0.006597862,0.9744067],"study_design_scores_gemma":[0.001257614,0.00007845744,0.00002499895,0.02563838,0.0004305876,0.0006020453,0.00003196555,0.00001994404,0.00005422909,0.0001422718,0.9712223,0.000497152],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004749699,0.9895899,0.00003840054,0.0001946132,0.0001612077,0.001741336,0.0001653771,0.0001547024,0.007479501],"genre_scores_gemma":[0.00007103768,0.9827378,0.0004905657,0.0002425095,0.0004860297,0.000619101,0.0003786603,0.0001909177,0.01478339],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9739096,"threshold_uncertainty_score":0.9997664,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2013781993","doi":"10.1038/nrc2047","title":"Myelodysplastic syndromes: the complexity of stem-cell diseases","year":2007,"lang":"en","type":"review","venue":"Nature reviews. Cancer","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":341,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Leukemia and Lymphoma Society; Diamond Blackfan Anemia Foundation","keywords":"Myelodysplastic syndromes; Bone marrow failure; Context (archaeology); Stem cell; Bone marrow; Haematopoiesis; Disease; Population; Myeloid; Medicine; Myeloid leukemia; Immunology; Biology; Bioinformatics; Cancer research; Internal medicine; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.1508113466278607,"gpt":0.4384797511620897,"spread":0.2876684045342289,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001188818,0.0009091549,0.00577112,0.0003732849,0.0001295088,0.00002842674,0.00106448,0.001199648,0.000964756],"category_scores_gemma":[0.0003219994,0.0004576147,0.001857922,0.001774401,0.0009296014,0.0000630547,0.0003052262,0.004570142,0.0003330139],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001371474,"about_ca_system_score_gemma":0.00279353,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004963612,"about_ca_topic_score_gemma":0.00002459896,"domain_scores_codex":[0.994897,0.0006482499,0.001663218,0.0008334154,0.00118318,0.0007749004],"domain_scores_gemma":[0.9952001,0.001108584,0.001175708,0.001731871,0.0003732691,0.0004104928],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002999931,0.00008955278,0.000009600961,0.1730286,0.0003197825,0.00007573575,0.00001697643,9.334883e-8,4.420682e-7,0.0001752373,0.03920752,0.7870464],"study_design_scores_gemma":[0.0004163496,0.00009077545,0.00003437773,0.07237457,0.005143994,0.0002128003,0.000009618823,0.000002591056,0.000001959583,0.00001513577,0.9213415,0.0003563571],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002381728,0.9911277,0.0000221557,0.0002398117,0.0006421866,0.005227361,0.0006349156,0.00005219506,0.002051332],"genre_scores_gemma":[0.00001529611,0.993429,0.0001596421,0.0005688652,0.0009081949,0.0006162,0.0002746686,0.0001512759,0.003876825],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.882134,"threshold_uncertainty_score":0.9999485,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4281569605","doi":"10.1038/s41591-022-01819-x","title":"A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia","year":2022,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":338,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; British Columbia Institute of Technology; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Myeloid leukemia; Leukemia; Computational biology; Biomarker; Biology; Progenitor cell; Drug response; Transcriptome; Disease; Medicine; Bioinformatics; Stem cell; Cancer research; Drug; Immunology; Gene; Internal medicine; Genetics; Gene expression; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.02736428066932103,"gpt":0.3283588931642211,"spread":0.3009946124949,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004199733,0.0003287086,0.000716423,0.0008139436,0.0004915854,0.00001849462,0.0003021772,0.0003785462,0.0001273814],"category_scores_gemma":[0.003476781,0.0002817937,0.0001058573,0.001104217,0.0003262257,0.0000920996,0.0003884732,0.004303124,0.000001550878],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004314163,"about_ca_system_score_gemma":0.0007035093,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006674687,"about_ca_topic_score_gemma":0.00002444603,"domain_scores_codex":[0.9963887,0.0004725374,0.0005247924,0.0007569169,0.00108748,0.0007695506],"domain_scores_gemma":[0.9960157,0.002807988,0.000151037,0.0005572274,0.00009580934,0.0003722695],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1419508,0.0007474886,0.1735423,0.002932946,0.002602232,0.01159069,0.0407295,0.0003728128,0.5056708,0.0484443,0.06049812,0.01091798],"study_design_scores_gemma":[0.1565756,0.02956309,0.1178489,0.008284986,0.003946588,0.008594952,0.08632763,0.09182885,0.09351949,0.1644512,0.2338639,0.005194739],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9593996,0.005476953,0.008250128,0.02431928,0.0005010241,0.00164891,0.00006725777,0.0001237372,0.0002131278],"genre_scores_gemma":[0.9900995,0.0002111139,0.004701828,0.003395383,0.000587335,0.0002532365,0.0001208394,0.00008605993,0.000544654],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4121513,"threshold_uncertainty_score":0.9999634,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2055884944","doi":"10.1182/blood-2013-12-540971","title":"Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":336,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"Celator Pharmaceuticals","keywords":"Daunorubicin; Cytarabine; Medicine; Internal medicine; Leukemia; Oncology; Gastroenterology","retraction":null,"screen_n_in":null,"score":{"opus":0.008712615199877411,"gpt":0.268214824499536,"spread":0.2595022092996586,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009577667,0.0005052909,0.001529845,0.0007359299,0.00006023442,0.00001729164,0.0003903792,0.0003399307,0.0003240336],"category_scores_gemma":[0.0008751726,0.0003922009,0.000213194,0.001327402,0.0003340755,0.0001795989,0.0001089218,0.0006907537,0.00003701594],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001604776,"about_ca_system_score_gemma":0.0007479514,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001602901,"about_ca_topic_score_gemma":0.0002962342,"domain_scores_codex":[0.995753,0.0003980462,0.00126233,0.0007557084,0.001051444,0.0007793996],"domain_scores_gemma":[0.9970293,0.0004016994,0.0004665153,0.001159635,0.0006102259,0.0003326374],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5137882,0.03905704,0.03701603,0.002296429,0.001571664,0.0008839256,0.005277124,0.0001782032,0.3881347,0.0004076464,0.003517537,0.007871539],"study_design_scores_gemma":[0.6331099,0.0188203,0.009557768,0.001212649,0.0006170558,0.0001152041,0.000330019,0.003215512,0.3321724,0.00002246691,0.0003777319,0.0004490896],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941513,0.0002021686,0.0003339314,0.0006418453,0.00007716498,0.003051094,0.0000704308,0.00008437615,0.0013877],"genre_scores_gemma":[0.9969743,0.00009943559,0.001292958,0.0001844252,0.000282208,0.0001631753,0.0002534852,0.0001011514,0.000648797],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1193217,"threshold_uncertainty_score":0.999853,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1970504500","doi":"10.1038/ng.3253","title":"Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia","year":2015,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":329,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; University Health Network; Toronto Western Hospital; Hospital for Sick Children; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institute of General Medical Sciences; National Institutes of Health; National Cancer Institute; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Biology; Mutation; Cancer research; Genetics; Leukemia; Germline mutation; Exon; Exome sequencing; Molecular biology; Immunology; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01593605375899439,"gpt":0.2855705755787774,"spread":0.269634521819783,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002563473,0.0002101463,0.0003718194,0.0002628635,0.0000600695,0.00004039253,0.0001293416,0.0004638278,0.00001473591],"category_scores_gemma":[0.0004596864,0.0001806203,0.00002900641,0.0007814706,0.00007566842,0.00005509546,0.0001020856,0.0007162898,0.00001932226],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001717222,"about_ca_system_score_gemma":0.0008407257,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003091427,"about_ca_topic_score_gemma":0.0003812605,"domain_scores_codex":[0.9983061,0.00007875609,0.0002550285,0.0004046162,0.0005671768,0.0003883263],"domain_scores_gemma":[0.9986133,0.0001141666,0.00009364438,0.0003003592,0.000469333,0.0004091848],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00676746,0.001415515,0.7807555,0.0006874194,0.000596399,0.002440732,0.01084007,0.01357392,0.1131254,0.00005188047,0.06426936,0.005476405],"study_design_scores_gemma":[0.01217296,0.001595926,0.9393632,0.0005164007,0.0002992689,0.0001538833,0.0008945084,0.01002259,0.03313977,0.0001497449,0.001228528,0.0004631833],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956679,0.0007772396,0.0001907493,0.001362549,0.00006964026,0.0007889789,0.00007060196,0.00005515532,0.001017138],"genre_scores_gemma":[0.9932322,0.00006915396,0.004772033,0.0008381848,0.0001209834,0.00004576869,0.0002169535,0.00005032657,0.0006543815],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1586078,"threshold_uncertainty_score":0.7365481,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2129652709","doi":"10.1182/blood-2003-01-0013","title":"GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":325,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Acute megakaryoblastic leukemia; GATA1; Down syndrome; Trisomy; Leukemia; Medicine; Myeloid leukemia; Acute leukemia; Mutation; Haematopoiesis; Cancer research; Immunology; Genetics; Biology; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01172593057485609,"gpt":0.2629574799329259,"spread":0.2512315493580698,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002998203,0.0001905226,0.0004681216,0.0003507639,0.00005010049,0.00001322896,0.0001085367,0.000145194,0.0001334222],"category_scores_gemma":[0.0002463218,0.00017263,0.00007535164,0.0005886227,0.0002080899,0.0001039468,0.00003072061,0.0004123675,0.00002953003],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004902857,"about_ca_system_score_gemma":0.001360192,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001457779,"about_ca_topic_score_gemma":0.00004286067,"domain_scores_codex":[0.998324,0.00008756942,0.0004351768,0.0003560852,0.0003829888,0.0004142224],"domain_scores_gemma":[0.9990638,0.0001962458,0.00006686726,0.0003576241,0.00008896509,0.0002264961],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.002243919,0.005545125,0.1621638,0.004734056,0.005473096,0.02984907,0.01486247,0.001396646,0.7436426,0.01605656,0.005235726,0.008796941],"study_design_scores_gemma":[0.06205937,0.00382969,0.7442916,0.001292454,0.003041001,0.01993534,0.001606816,0.002743555,0.1554878,0.001518422,0.002992953,0.001200961],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939864,0.0003927,0.0001405251,0.0001817138,0.00003947056,0.0005285885,0.00003430184,0.00003511349,0.004661167],"genre_scores_gemma":[0.9967161,0.0001493008,0.002208064,0.00009282458,0.0000158092,0.0000481073,0.00003244196,0.00003296883,0.0007044257],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5881548,"threshold_uncertainty_score":0.7039647,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2169007954","doi":"10.1200/jco.2008.19.6550","title":"Multicenter Study of Decitabine Administered Daily for 5 Days Every 4 Weeks to Adults With Myelodysplastic Syndromes: The Alternative Dosing for Outpatient Treatment (ADOPT) Trial","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":314,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research","funders":"American Society of Clinical Oncology","keywords":"Medicine; Decitabine; Myelodysplastic syndromes; International Prognostic Scoring System; Dosing; Regimen; Hypomethylating agent; Internal medicine; Complete response; Clinical trial; Clinical endpoint; Oncology; Chemotherapy; Bone marrow","retraction":null,"screen_n_in":null,"score":{"opus":0.1620961550530729,"gpt":0.4795324990879281,"spread":0.3174363440348552,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002626436,0.0002557312,0.00198137,0.0002175618,0.00008939236,0.00001650957,0.000343284,0.0002158903,0.00001415156],"category_scores_gemma":[0.007477325,0.0001282145,0.0005039326,0.0001698571,0.0001363502,0.00009801447,0.00005307165,0.0005499626,0.000002835999],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007794534,"about_ca_system_score_gemma":0.001866088,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002478789,"about_ca_topic_score_gemma":0.00008724515,"domain_scores_codex":[0.9953281,0.0004847489,0.002782825,0.0003520757,0.00063805,0.0004142219],"domain_scores_gemma":[0.9857709,0.01031962,0.001827521,0.0003657053,0.001251374,0.0004648614],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8756524,0.01931164,0.002850909,0.00004179353,0.001659252,0.0003412777,0.004247786,0.0001729037,0.00006427692,0.00001257406,0.001256825,0.09438841],"study_design_scores_gemma":[0.3512227,0.603657,0.03375965,0.0003519291,0.001271514,0.0001138775,0.003749894,0.00120891,0.0001127348,0.00002933083,0.004399091,0.0001233258],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9848749,0.00005390539,0.002667083,0.005187266,0.0009596711,0.006140552,0.00002856521,0.00000633703,0.00008173213],"genre_scores_gemma":[0.9884652,0.00005206974,0.008857443,0.0009963788,0.00125796,0.0001484345,0.000006678051,0.00002823541,0.0001875923],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5843454,"threshold_uncertainty_score":0.8951597,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2162079601","doi":"10.1038/ng.3400","title":"The genomic landscape of juvenile myelomonocytic leukemia","year":2015,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":309,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Biology; Juvenile myelomonocytic leukemia; Juvenile; Chronic myelomonocytic leukemia; Genetics; Evolutionary biology; Leukemia; Computational biology; Immunology; Myelodysplastic syndromes","retraction":null,"screen_n_in":null,"score":{"opus":0.02087007176139491,"gpt":0.3014621779574562,"spread":0.2805921061960612,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005193667,0.0001382257,0.000263704,0.00008265881,0.00006751397,0.00001988009,0.0003389512,0.0003543524,0.00002451475],"category_scores_gemma":[0.0003801292,0.00008984961,0.00008423088,0.0002840619,0.0001463001,0.00001710165,0.0001603398,0.0009071123,0.00009082964],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005174285,"about_ca_system_score_gemma":0.001918869,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001175146,"about_ca_topic_score_gemma":0.00001495391,"domain_scores_codex":[0.9986005,0.00005033086,0.0002816489,0.0002093796,0.0005126531,0.0003454318],"domain_scores_gemma":[0.998526,0.0001302078,0.00009147458,0.000652898,0.0003594129,0.0002399524],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002499729,0.0001835202,0.1103578,0.0003571727,0.0007129047,0.0002987532,0.002549827,0.0010629,0.04139322,0.001293637,0.7311438,0.1081467],"study_design_scores_gemma":[0.007878839,0.001205795,0.1034383,0.00008251101,0.000303032,0.000403842,0.001288264,0.01399955,0.05630474,0.001674565,0.8129797,0.0004408752],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9635635,0.02054896,0.00004231786,0.001150729,0.0003735903,0.0003738482,0.00001122002,0.00003675263,0.01389906],"genre_scores_gemma":[0.9929052,0.0007812331,0.002256303,0.0003729934,0.0004502471,0.000009954329,0.00002021799,0.00003679274,0.003167075],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1077058,"threshold_uncertainty_score":0.3941002,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3206778834","doi":"10.1038/s41591-021-01521-4","title":"Distinction of lymphoid and myeloid clonal hematopoiesis","year":2021,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":298,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Howard Hughes Medical Institute; Medical Research Council; Fondation Leducq; Massachusetts General Hospital; Knut och Alice Wallenbergs Stiftelse; Deutsche Forschungsgemeinschaft; Damon Runyon Cancer Research Foundation; Leukemia and Lymphoma Society; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Myeloid; Haematopoiesis; Somatic cell; Biology; Immunology; Somatic evolution in cancer; Lineage (genetic); Cancer; Gene; Genetics; Stem cell","retraction":null,"screen_n_in":null,"score":{"opus":0.01011401987861053,"gpt":0.3045070579499828,"spread":0.2943930380713722,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000367896,0.0001525115,0.0004928897,0.0001557291,0.00005480104,0.000004072543,0.00006923389,0.0003102223,0.0007667725],"category_scores_gemma":[0.001528803,0.0001103681,0.00005644196,0.0005308985,0.0003309627,0.00004531968,0.0000867886,0.0006797271,0.0000085459],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001472542,"about_ca_system_score_gemma":0.0003383807,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004043957,"about_ca_topic_score_gemma":0.00001187032,"domain_scores_codex":[0.9984368,0.00005362695,0.0003032398,0.0003173816,0.0006577464,0.0002311946],"domain_scores_gemma":[0.9986761,0.0002391627,0.00008117074,0.000338796,0.0004558104,0.0002089946],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001614397,0.0004190269,0.1016994,0.002563072,0.0005740226,0.001871611,0.001222413,9.41462e-7,0.748623,0.01087862,0.08165353,0.04888001],"study_design_scores_gemma":[0.01784264,0.00133625,0.3473334,0.00191033,0.0007676625,0.01253193,0.002262665,0.0005449588,0.4597737,0.001913564,0.153301,0.0004819568],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9467216,0.01470013,0.0002562036,0.02249588,0.0003692512,0.000236083,0.00001384244,0.00005671162,0.01515027],"genre_scores_gemma":[0.9917262,0.0007304237,0.001429397,0.001615852,0.0007214246,0.000008195012,0.00012152,0.00002453994,0.003622429],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2888493,"threshold_uncertainty_score":0.8395622,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}